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                                               A  Dissertation  on 
“A  COMPARATIVE  ANALYSIS  OF  DEPRESSION,  ANXIETYY  AND  
QUALITY  OF  SEXUAL  FUNCTION  IN  TYPE 2   DIABETESS 
MELLITUS  PATIENTS  IN  A  TERTIARY  CARE  HOSPITAL.” 
 
AIM : To  compare  the  anxiety , depression , Quality  of  sexual  function  
between  cases(type 2 DM))  and  controls (Non – diabetic  individuals). 
 
MATERIALS AND METHODS : M.I.N.I , Beck  depression  inventory(BDI) , 
Ham-A , Quality  of  sexual  function  scale(QSF).  
 
PROCEDURE : Type 2 DM  patients  were  recruited  into  the  study  based  on  
inclusion  and  exclusion  criteria  and  were  compared  with  age,  sex  matched  
controls  non  diabetic  individuals  from  medicine  OPD. Participants  were  
assessed  with   the  above  scales  cross -  sectionaly.  
 
RESULTS :  Prevalence  of  depression  and  anxiety  was  high  in  type 2 DM  
patients. Quality  of  sexual  function  is  significantly  impaired  in  type2 DM  
patients  compared  to  controls. 
 
CONCLUSION : Type 2 DM  patients  must  need  consultation  liaison  
psychiatry  to  identify  any  psychiatric  illness , to  prevent  or  postpone  their  
complications , since  both  mutually  worsen  each  other .  
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INTRODUCTION 
 
Diabetes  mellitus  is  metabolic  disease  in  which  an  increased  level  of  
blood  glucose  results,  due  to  the  alterations  in  the  insulin  secretion  or  by  an  
impaired  action  of  insulin  or  by  the  combined  effects  of  the  above  
mentioned.  The  various  target  end  organs,  especially  the  eyes,  kidneys,  
nerves,  heart,  and  blood  vessels   undergo  damage,  alteration  in  their  
functions,  and  may  go  for  failure  due to  an  increased  blood  glucose  for  a  
prolonged  period  of  time (Chronic  Hyperglycemia).   
 
Long-term  complications  of  diabetes  include  retinopathy  (with potential 
loss of vision),  nephropathy  (leading  to  renal  failure),  peripheral neuropathy  
with  risk  of  foot  ulcers,  with  diabetes  have  an  increased  incidence  of  
atherosclerotic cardio-vascular,  peripheral  vascular,  and  cerebro-vascular 
disease. Hypertension  and  lipoprotein  metabolism  abnormalities  are  frequently  
found  in  people  with  diabetes  mellitus. 
 
World Health Organization (WHO)  estimated  that  the  number  of   
diabetic patients  world-wide  in  2000  was  171  million  and  which  is  expected 
to increase  to  366  million  by  2030. In   addition  to  that,  approximately  197 
million  people  world – wide  have  impaired  glucose  tolerance (IGT),  a  pre-
diabetic  state;  and  it  is  expected  to  rise  in  amount   to  420  million  by 
2025.(1) 
 
The  fact  of   great  concern  is that  the  highest  increase  in  the  number  of   
people  with  diabetes  is  expected  to  increase  by  three-fold. 
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According  to  International  Diabetes  Federation (IDF),  India  has  the  
largest  number  of  diabetic  patients  Globally,  and   now,  the number  of  
diabetic  patients  in  India  are  around  40.9  million   and  it  is  expected  that,  
there  will  be  69.9  million  diabetic  population  in  India  by 2025. (Diabetes  
Atlas – 6th  edition).According  to  this  data,  India  is  the   fast  becoming  the  
“diabetes  capital  of  the  world”.  
 
There  is  a  certain  exclusive  clinical  and  biochemical  abnormalities  
among  Asians, especially  among  Indians  which  includes  increased  insulin - 
resistance,  increased  abdominal  adiposity ( i.e., elevated  waist  circumference  
even  though   low  BMI (Body Mass Index),  decreased  adiponectin  and   
increased  level  of  of  high  sensitive  C-reactive  protein) : so  called  "Asian  
Indian  Phenotype". This  phenotype  among   Asian,  especially  Indians  are  more  
vulnerable  to  diabetes  mellitus  and  earlier  coronary  arterial  disease,  also  a  
part  of  this  is  may  be  due  to  genetic linkage. Moreover, the  primary reason  
of  the  epidemic  of  diabetes  mellitus  is  the  rapid  epidemiological  changes  
like  as  modifications  in  life – style,  rapid  industrialization  in  the  urban  areas,  
which  lead  to  modifications   in  dietary  patterns  and  poor  physical  activity  as 
evident  from  the  increased  occurrence  of  diabetes  mellitus  in   the  urban – 
population. (2) 
Globally,  the  prevalence  of  diabetes  was  4.7  per cent among  the  urban  
population  when  compared  to  the  rural population  was  2.0 per cent  according 
to  the  American  Diabetes  Association (ADA) criteria  ,  but  according  to  the  
WHO  criteria   the  prevalence  of  diabetes  mellitus  was  5.6 % among  urban  
and   2.7 %  among  rural  populations ..(3)  
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In  India,  there  has  been  consistent reports  of  differences  in  the  
prevalence  of   diabetes  mellitus  between  urban  and  rural  population. The  
ICMR  study reported  that  the  prevalence  of  diabetes  in  urban  areas  was  2.1 
per cent  and  in  rural  areas  was 1.5  per cent,  where  as  an  earlier  study  
showed  that  the  prevalence  was  3  times  higher  in  the  urban  areas (8.2%)  
when  compared with  the  rural  areas  (2.4%). (4) 
 
According  to  the  WHO-ICMR  national  NCD (Non  Communicable  
Diseases)  risk  factor  surveillance  at 2006,  a  surveillance  was  conducted  in 5  
States of India,  in  a  different  geographical  locations  (which  includes  northern, 
southern,  eastern  and  western/central  India)  indicated  that  the  Urban  area  
had  the  higher  prevalence (7.3%), followed  by  peri-urban/slum (3.2%)  and  
rural   areas (3.1%).(5) 
 
 In  a  study  at  Chennai, Chennai  Urban  Rural  Epidemiology  Study  
(CURES),   the  overall  crude  prevalence  of  diabetes  mellitus  using  WHO  
criteria,  was  15.5 % (age - standardized: 14.3%), while  that  of   Impaired  
Glucose  Tolerance  was 10.6 %  (age - standardized: 10.2%). The  prevalence  of  
diabetes  mellitus  in  Chennai  was  increased  by  39.8% (From 8.3%  to  11.6%)  
in  the  period  of  1989-1995,  between  period  of  1995 - 2000  the  prevalence  
rate  increased  to 16.3 % (From  11.6%  to  13.5%),  and  between  the  period  of  
2000 - 2004,  the prevalence  rate  further  increased  to 6.0% (From  13.5%  to 
14.3%).  These  results  shows  that  in  Chennai  itself  within  the  period  of  14  
years,  the  prevalence  of  diabetes  mellitus  increased  markedly  to  72.3%.(6)   
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Diabetes  mellitus  is  a  highly  prevalent  public  health  problem,  and  
having  reached  an  epidemic  status  worldwide.  Diabetes  mellitus  contributes  
to  a  markedly  increased  morbidity  and  mortality  in  a  large  segment  of  
people  Globally,  and  mainly  because  of  its  extensive  complications. In  a 
study  of  Diabetes  Attitudes,  Wishes,  and  Needs  (DAWN),  surveyed  over  
4000 clinicians  across  13  countries  who  treating  diabetes  mellitus  patients,  
more than  three – fourths  of clinicians  declared  that  the  psychological  
problems – i.e; disorders   (or)  high  levels  of  diabetes  related  distress,  
interfered  with their  patient’s  drug  compliance.(7) 
 
Diabetes  and  psychiatric morbidities  such  as  depression,  anxiety,  and  
sexual dysfunctions   are  common,  they  are  likely  to co-exist,  but  importantly  
either  one  is  known  to  worsen  the  other.  Psychological  stress  after  the 
diagnosis  of  diabetes  may  worsen  hyperglycaemia,  initiated  by  hypothalamo-
pituitary-adrenal (HPA-Axis)  axis. 
 
Recent  studies  shows  that  the  occurrence  of  depression  and  anxiety 
increased  3  times  in  diabetic  patients  when  compare  to  the  general  
population. Also, depression  among  the diabetes  mellitus  patients   is  strongly  
associated  with  higher  levels  of  HbA1C  with  less active  self – care  leads  to  
increased  complications,  mortality, and  expenditures of  health  care.  It  is  
worthy  to  note  that  even  relatively  low  levels  of  depression  may  be  
associated  with  these  negative  clinical  out – comes. (8)    
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Identifying  co-morbid  psychiatric  conditions  like  depression,  anxiety  
and  sexual  dysfunction  is  essential  to  reduce  the  disability  due  to  diabetes. 
However,  it  has  been  noted  that  in  some  situations  psychiatric  illnesses  are  
under - recognized  by  physicians ,  because  of   a  wrong  consideration  of  
psychiatric  morbidities  (Depression,  Anxiety  and  sexual  dysfunctions)  as  
a‘normal  consequences of  difficult  medical  illnesses’-(Lustman  et  al).(9) 
 
Nowadays,  the  co-morbidity  of  psychiatric  illnesses  with  long-  term 
physical  illnesses  like  diabetes  has  emerged  as  a considerable  attention  to  
both clinical  and  policy issues. Diabetes  is  one  of  the  most  psychologically  
demanding  illness, requires  strict  daily  management  by  the  patients  
themselves.  Besides  the  stress  of  living  with  diabetes,  diabetics  also  have  to  
deal  with  the  fear  of  complications  secondary  to  diabetes, which  lead  to  
depression,  anxiety  and   also  affects  the  quality  of  sexual  functions  in  both  
genders. 
 
Chronic  hyperglycaemia  is  known  to  induce  worsening  of  sexual  
functions  like  decreased   sexual  desire,  sexual  aversion  disorder,  difficulty  in  
erection,  difficulty  in  achieving  orgasm,  and  premature  ejaculation  in  men. 
Prevalence  of  erectile  dysfunction (ED) in  men  with  diabetes  increases  with  
age  and  is  about  35-70%  overall.     
In  women  with  diabetes,  sexual  dysfunction  is  less  common  and  
usually  undeclared,  but  there  is  an  increased  risk  of  vaginal  dryness  and  
arousal  disorder.  
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I dentification  and  management  of  psychiatric  co-morbidities  like  
depression,  anxiety  and  sexual  dysfunction  in  diabetes  patients  may  have  a  
favourable  outcome  on  good  glycemic  control  and  even  prevent  or  postpone  
the  diabetes  related  complications. 
 
There  is  a  marked  difference  in  the  prevalence  of  psychiatric  co-
morbidity between  Type 1  and  Type  2  diabetes  mellitus, because of : (1) the 
age  of  onset in  type 1  diabetic  patients, is  markedly  different  with  type 2  
diabetic patients:(2) the  cause  of  depression  in  type  2  diabetes  is  also  
different  from  that  in  type  1  diabetes: (3) type 2   diabetes people  are  
vulnerable  to  have  co-morbid  conditions,  like  obesity,  hypertension -  an  
another  risk  factors  for  depression: (4) the  occurrence  of  complications  in  
type 2  diabetes  occurs  earlier  than  to  type 1  diabetes: (5) the treatment  of  
both type 1  and  type 2  diabetes  mellitus  are  different  and  developing  a  
different  psychological  burdens. So,  type 1  and  type 2  diabetes  mellitus  and  
it’s  complications  never  to  be  comparable. 
 
Diabetes  and  its  both  micro – vascular  and  macro – vascular  
complications  like  diabetic  retinopathy,  diabetic autonomic  neuropathy, diabetic  
nephropathy,  diabetic  neuropathy,   cardiovascular complications,  hypertension,  
and  lipid  abnormalities  are  themselves  as  a  risk  factors for  depression  and  
anxiety.  So,  thorough  clinical  evaluation  done  to  avoid  confounding  factors  
to  assess  depression  and  anxiety  in  this  study.  Also  a  thorough  clinical  
evaluation  of  medications  that  affect  the  quality  of  sexual  functions  was  
done  to  avoid confounding  factors  to  assess  the quality  of  sexual  functions  in  
type 2  diabetes  mellitus  patients. So,  it  is  necessary   to study  a  comparative  
analysis  of  psychiatric  co- morbidities  like  depression,  anxiety,   and  quality  
of  sexual  functions  in  type 2  diabetes  mellitus  patients  to  an  age  matched  
non – diabetic  individuals  in  elaborately. 
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DEPRESSION: A  VIGNETTE 
 
According  to  ICD – 10,  an  individual  is  said  to  be  in  depression  either  
mild,  moderate  or  severe   who  usually  suffers  with  typical  symptoms  of  
depressed  mood,  loss  of  interest  and  decreased  energy  that  may  lead  to  
increased  fatigability  and  decreased  activity. 
The  various  other  symptoms  are 
(1)  Decreased  attention  and  concentration, 
(2)  Decreased  self – esteem  and  self – confidence, 
(3)  Guilty  feelings  and  worthlessness 
(4)  Negative  view  about  the  future, 
(5)  Self – harm  or  suicidal  thoughts, 
(6)  Sleep  disturbances, 
(7)  Lack  of  appetite. 
 
Depression  can  be  categorized  in  to  mild,  moderate  and  severe,  
according  to  the  number  of   typical  symptoms  and  the  various  other  
symptoms.  For  the  diagnosis  of  depression,  these  symptoms  should  persists  
for  about  2  weeks  and  cause  significant  impairment  in  social  and   
occupational  functioning. 
Depression  can  occur  alone  or  as  a  part  of  Bipolar  disorder. If  it  
occurs  alone,  then  it  is  known  as  Unipolar  depression.  Depression  is  more  
among  in  women  than  men  with  the  ratio  of  2 : 1.At least  25 %  of  the  
patients  had  one  or  more  precipitating  events.There  is  also  a  diurnal  
variation  in  the  symptoms :  the  symptoms  worse  in  the  morning. 
Approximately  75%  of  depressed  patients  experienced  sleep  disturbances,  
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either  insomnia  or  hypersomnia. About  60 %  of  the  depressed  patients  have  
suicidal  ideation  and  15%  commit  suicide. 
 
DEPRESSION  IN  DIABETES  MELLITUS  PATIENTS 
 
CAUSES  OF  DEPRESSION  IN  DIABETES  MELLITUS 
 
According  to  Lustman  P J Griffith et al ,(10)  various  hypotheses  have  
been  proposed  to  understand  the  relationship  between  diabetes  mellitus  and   
depression. 
1.  Depression  may  occur  as  a  result  of  psycho  social  stressors  caused  
     by  diabetes  mellitus. 
2.  Depression  may  occur  as  a  result  of  biochemical  changes  related  to   
     diabetes  mellitus  and  its   treatment,  since  diabetes  mellitus  and  depression   
     are  parts  of  a  common  set  of  metabolic  disorders. 
3.  The  chronic  course  of  diabetes  and  the  stress  caused  by  it  and  the   
     duration  of  the  diabetes  mellitus  and  its  complications  may  affect  the   
     quality  of  life  significantly. 
4.  An  abnormal  production  of  cortisol  was  demonstrated  with  both  in   
    diabetes  mellitus  and  depression,  since  in  both  conditions  there  is  an   
    altered  functions  of  hypothalamo  –  pituitary –  adrenocortical (HPA)  axis. 
5.  In  diabetes  mellitus  patients,  there  is  a  frequent  changes  in  blood  glucose   
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     level  either  hyperglycemia  or  hypoglycemia.  These  shift  in  blood   
     glucose  level  also  influences  the  shift  in  mood:  present  as  euphoria,   
     depression  or  dysphoria. Presence  of  poor  glycemic control  in  long  term   
     lead  to  a  high  risk  of  affective  disorders. 
6.  Both  diabetes  mellitus  and  depression  are  prevalent  independently, 
     but  also  both  may  exist  together  accidently. 
 
PSYCHO  SOCIAL  THEORY: 
Psycho  analytic  view: 
According  to  Sigmund  Freud,  if  an  object  is  lost  or  perceived  as  lost, 
there  is  an  internalized  ambivalence  occurred  towards  the  loved  object  or  
person  which  can  produce  a  form  of  pathological  mourning  may  expressed  
as  guilty  feelings worthlessness  and  suicidal  ideation. The  symbolic  or  a  real  
loss  of  loved  object  is  perceived  as  rejection.  In  diabetes  mellitus  patients,  
the  symbolic  loss  may  be  an  altered  body  image,  limitations  in  social  
functioning  and  a  strict  diet  restrictions:  which  may  be a  key  tool  in  the  
occurrence  of  depression. 
 
Other  Psycho  Dynamic  view: 
Introjection  play   as  an  important  key  tool  in  the  causation  of  
depression  in  diabetes  mellitus  patients,  since  lost  object  viewed  
ambivalently  by introjection:  which  lead  to  an  inner  sense  of  guilt,  conflict,  
rage,  pain  and  loathing in  depression. 
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LEARNED  HELPLESSNESS  THEORY: 
Martin  Seligman  advocated  this  learned  helplessness  model  in  the  
causation  of  depression. This  theory  is  derived  from  the  observed  behavior  
of  animals  experimentally  given  un – expected  random  electric  shocks,  from  
which  they  learned  to  cannot  escape. 
 
This  theory  attributes  that  a  person  with  inability  to  control  the  
events,  learned  to  a  behavioral  passivity  like  a  sense  of  powerless  and  
helpless. In  diabetes  mellitus  patients,  control  of  blood  sugar  is  beyond  their  
intentions,  and  they  should  be  in  surrender  to  medical  treatment  and  on  
dependent  to  seeking  medical  consultations  periodically. This  will  lead  to  a  
causation  of  depression  in  diabetes  mellitus  patients. 
BEHAVIORAL  THEORY: 
Lewinshon  postulated  that,  if  the  reinforcement  from  the  environment  
is  low, it  will  precipitate  depression  in an individual. In  a  diabetic  individual,  
the  reinforcements  like  pleasurable  activities  and  social  interactions  were  
low,  this  in  turn  lead  to  them  in  depression. 
 
COGNITVE  THEORY: 
Cognitive  triad  postulated  by  Aaron  Beck  are  (i) Negative  view  of  
self,  (ii) Negative  interpretation  of  the  environment  and (iii) Negative  view  of  
future. According  to  Aaron  Beck,  cognitive  distortions  lead  to a  mal – 
adaptive  thinking  without  an  individual’s  conscious  awareness. 
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IMMUNOLOGICAL  THEORY: 
Herbet  et  al (11) postulated  that  the  immunological  abnormalities  caused  
by  depression  may  be  associated  with  the  causation  of  diabetes  mellitus. 
Depression  is  associated  with  several  immunological  abnormalities.  There  is  
an  elevated  serum  concentrations  of  the  cytokines ( Interleukin 1  and  
Interleukin  6 ),  Also  there is  an  increased  acute -  phase  proteins  like  CRP,  
haptoglobulin  and  an  alpha 1 – acid  glycol - proteins. These  immunological  
abnormalities  play  a  vital  role  in  the  causation  of  diabetes  mellitus.  
 
STRESS  AND  IMMUNE  RESPONSE  THEORY: 
Diabetic  patients  are  living  with  various  psychological  stresses  like  life  
long  medications,  life – style  modifications  and  strict  diet  restrictions. These  
psychological  has  been  associated  with  impaired  cellular  immunity. Also  
stress  induces  pro – inflammatory  cytokines,  as  evidenced  by  administration  
of  cytokines  in  clinical  trials  has  been  associated  with  the  development  of  
depressive  syndrome; ( Sickness  Behavior ). 
NEURO – HORMONAL  THEORY: 
According  to  Hans Selye,  an  elevated  HPA  activity  is  the  hall – mark  
of  mammalian  stress  responses,  and  have  a  clear – cut  linkage  with  
depression  and  the  biology  of  chronic  stress. Hyper  cotisolemia  in  depression  
may  lead  to  decreased  Serotonin  inhibitory  tone,  increased  Nor – epinephrine,   
Acetyl – choline  and  Corticotropin  Releasing  Hormone (CRH)  tone. Also  there  
is   a  decreased  feedback  inhibition  from  Hippocampus. 
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According  to  Lustman  et  al,(12) hyperglycemia  is  associated  with  
elevated  plasma  cortisol  level, which  in  turn  lead  to  initiation  of  mood  
changes.Earlier  Ettigi  et  al  proposed  that  an  abnormal  levels  of  plasma  
cortisol in  depressed  diabetic  patients. 
Dinan  et  al  proposed  that  in  diabetes  mellitus  patients,  there  is  a  
common  occurrence  of  dysregulation  in the  neurotransmitters  due  to  elevated  
HPA  activity. 
Cameron  et  al  postulated  that,  there  is  a  common  neuro - endocrine  
basis  for  both  depression  and  diabetes  mellitus,  as  evidenced  by  an  insulin  
resistance  reported  in  both  conditions.  
Lustman  PJ  et  al,13  Hudson  et  al  proposed  that,  an  abnormal  response  
to  dexamethasone  suppression  test :  failure  to  suppress  cotisol  in  response  to  
dexamethasone  is  observed  in  both   depression as  well  as  in  diabetes   
mellitus. 
Neuro – transmitters  especially  serotonin  and  nor – epinephrine  
dysregulation  has  been  an  etiology  of  depression.  The  same  dysregulations  
are  noticed  in  animal  models  of  diabetes  mellitus,  demonstrated  by  Trulson  
et  al.   Govard  et  al  postulated  that  anti  depressants  reduce  hyperglycemia  
and  insulin  requirement  in  diabetes  mellitus  patients.Cooper  et  al  proposed  
that,  an  association  between  hypoglycemia  with  the  use  of  mono  amine  
oxidase  inhibitors  in  Type 2  Diabetes  mellitus  patients.Lustman  et  al 14 
demonsrated  an  increased  Epinephrine   growth  hormone  levels  observed  in  
both  depression  and  diabetes  mellitus. 
Eaton  et  al  demonstrated  the  connection   between  long  term  medical  
management,  dietary  restrictions  and  changes  in  physical  activities  observed  
in  both  diabetes  mellitus  and  depression. 
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GENETIC  FACTORS: 
Lustman  et  al,15  postulated  that  a  genetic  linkage  have  been  noticed  
with  increased  prevalence  of  depression  in  diabetic  individuals,  also  found  
that  the  genetics  of  patients  with  depression  and  diabetes  mellitus  tend  to  be  
similar. 
 
Gene  mapping  studies  in  an  unipolar  depression  found  that,  there  is  a  
strong evidence  of  linkage  to  the  locus  for  CREB1 (c Amp  Response  Element 
– Binding  protein)  on  chromosome  2. 
 
The  chromosomal  region  at  2q37  was  the  first  locus  to  be  identified  as  
being  significantly  linked  with  type 2  diabetes  mellitus  in a  whole – genome  
screen. 
 
Hanish  et  al 16 proposed  the  linkage  region  of  type 2  diabetes  mellitus  
in  Mexican – American  population  were  2q37, 15q21, 3p14. 
 
Maleki  et  al 17 proposed  that,  the  chromosomal  region  2q32  undergo  
gene  mutation:  neuro D1/BETA2, genes  found  to  be  mutated  in  Autosomal  
Dominant  Diabetes  or  Maturity – Onset – Diabetes  of  the  Young (MODY). 
 
Various  data  suggest  that, the  chromosomal  regions  like  chromosome 
18,  21, and  22  have  the  strong  association  with  the  Bipolar  Affective  
Disorders. There  are  four  different  loci  on  the  chromosome  18,  preferentially  
at  the  locus  of  18q  has  a  possible  parent - of – origin  effect:  transmitted  
through  the  mother. 
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The  chromosome  21q  shows  linkage  to  both  Schizophrenia  and  
Bipolar  Affective  Disorder.  
The  chromosome  18q  and  22q  are  the  two  regions  with  strongest  
evidence  for  linkage  to  Bipolar  Disorder. 
 
Parker  et  al,18  demonstrated  the  chromosomal  linkage  region   18p11  has  
strong   association  with  type 2  diabetes  mellitus   in  a  study  on  Scandinavian  
white  population. 
 
Linkage  analysis  suggest  that,  there is  an  association  between  the  
serotonin  transporter  gene  (17q11.1-12) with  depression,  treatment  response  and  
possibly  suicidal  behavior. 
Horikawa  et  al 19 and  Lindner  et  al  demonstrated  the  chromosomal  
region  17q12-q21 undergo  genetic  mutation:  HNF1β (MODY 5),  results  in  mild  
to  moderate  diabetes,  young  age  at  diagnosis,  non  diabetic  kidney  disease  
and  genital  malformations. 
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LIFETIME  PREVALENCE  RATES  OF  DEPRESSIVE  DISORDERS: 
 
According  to Rihmer Z, 20 Angst A et  al, the  lifetime  prevalence rates  
depressive  disorders  in  a  general  population  are : 
 
TYPE RANGE AVERAGE 
Major  depressive  
episode 
5 -17% 12% 
Dysthymic disorder 3 -6% 5% 
Minor depressive 
disorder 
10% - 
Recurrent brief 
depressive disorder 
16% - 
Full unipolar spectrum - 20 – 25% 
 
 
PREVALENCE  OF  DEPRESSION  IN  TYPE 2  DIABETES MELLITUS 
CONTROLLED  STUDIES: 
Controlled  studies  which  have  used  the  control  groups  may  allow  us  
for  better  comparisons.In  a  meta – analysis  study  by  Ali S  et  al ,212006,  10  
controlled  studies  were  reviewed,  which  include  7  community  based  
studies(Palinkar  et  al, 221991; Viinamaki  et  al, 231995, Amato  et  al,24 1996;  
Eaton  et  al,251996; Black  et  al, 261999; Gregg  et  al, 272000; Pouwer  et  al, 
282003), 2  primary care  based  studies  (Janet  Thomas  et  al,29 2003; Nicolas  et  
al, 302003)  and  1  secondary  care  based  study  (Saeed  and  Al-Dabbagh  et  al,31 
2003). 
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Various  assessment  scales  were  used  in  these  studies. BDI – Beck  
Depression  Inventory,  a  self  report  questionnaire  used  in  Palinkar  et  al, 
1991, CES-D (Centre  for Epidemiological  Studies  for  Depression) Scale  was  
used  in  Black  et  al, 1999;  and  Pouwer  et  al, 2003, 
Zung  depression  scale  was  used  in  Viinamaki  et  al, 1995,  and the 
Geriatric  depression  scale  was  used  in  Amato  et al, 1996;  and   Gregg  et  al, 
2000. Diagnostic  Interview  Schedule  for  DSM – IV  was  used  in  the  studies  
of  Thomas  et  al, 2003; Saeed  and  Al - Dabbagh  et  al, 2003;  and  in Eaton  et  
al,1996. 
This  meta-analysis  review  results  showed  a   higher  prevalence  of  
depression  among  type 2  diabetes  mellitus  patients  when  compare  with  non  
diabetic  individuals. (Odds Ratio;1.77,  95%  Confidence Interval; 1.5 – 2.0).  
These  findings  were  consistent  when  the  rates  were  determined  by  gender,  
sample  source,  depression  assessment  methods  and  by  geographical  location.  
According  to  this  meta-analysis, the  overall  prevalence  of  depression  
among  type 2  diabetes  patients  was  17.6%,  in which  the  female  patients  had  
a  higher  prevalence  (23%)  than  male  patients (12.8%). 
Anne  Engum  et  al, 322005,  conducted  a  large  population  study  and  
found  that,  the  prevalence  of  depression  among  type 2  diabetic  patients  was  
19%  and  in the  non  diabetic  control  groups  the  prevalence  was  10%. 
Shamsaei33  et  al, 2006,  conducted  a  study  in Iran  and  found  that  mean  Beck  
depression  score  among  type 2  diabetic  patients  was  higher  (18.6)  than  the  
non diabetic  control  groups (9.1). Mary de Groot34  et  al, 2007,  conducted  a  
community  based  study  in  type 2  diabetes  mellitus  patients   and  revealed  
that  31%  of  the  participants  showed  a  clinically  significant  depression  in  
Beck Depression  Inventory  Scale.  
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UNCONTROLLED  STUDIES: 
In  a  meta - analysis  study  of  Anderson35  et  al, 2001;  he  reviewed  22  
uncontrolled  studies  to  estimate  the  prevalence  of  depression  in  diabetic  
patients. According  to  this  study  the  overall  prevalence  of  depression  among  
diabetic  patients  was  29.7%. Among  the  22  uncontrolled  studies,  5  of  them  
evaluated  the  prevalence  of  depression  in  type 2  diabetic  patients (Biglan  et  
al,  Connell36  et  al,  Geringer37 et  al,  Marcus38et  al,  and  Nalibott39 et  al which  
showed  that  the  prevalence  of  depression  in  type 2  diabetic  patients  
washigher (Mean: 33.8%, Range: 18.8% - 47%)  than  the  type 1  diabetic patients 
(Mean: 21.2%,  Range: 11.5% - 42.4%). 
Among  the  22  uncontrolled  studies,  5  of  them  estimated  the  
prevalence  of  depression  in  male  and  female  diabetic  patients  separately 
(Bailoy  et  al,  Haire – Joshu  et  al,  Naliboff  et  al,  Peyrot40  et al,  and  
Slawson41 et  al) which  showed  that  the  prevalence  of  depression  was  greater  
in  females  (33%)  than  in  males (20.7%). 
 
In  a  recent study  at  Malaysia,  Kurubaran Ganasegeran42  et  al, 2014,  
demonstrated  the  factors  connected  with  depression  and  anxiety  among  type 
2  diabetic  patients. They  conducted a  descriptive   cross – sectional  study  in  a  
single  centre  and  found  that,  among  169  type 2  diabetic  patients (men, n=99; 
women, n=70),  depression  present  in  68  patients (40.3%), and  anxiety  present  
in  53  patients  (31.4%). Multivariate  analysis  of  this  study  shows  that,  theage  
of  onset,  ethnicity,  monthly  income  and  the  complications  associated  with  
diabetes  were  significantly  influenced   the  causation  of  both  depression  and  
anxiety  among  the  type 2  diabetic  patients.     
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INDIAN  STUDIES 
Poongothai S43,   et  al, and  her  colleagues   at  2009;  conducted  a  
population  based  study  to  estimate    the  prevalence  of  depression  in  an  
urban  south  Indian  population – Chennai  Urban  Rural  Epidemiology  Study 
(CURES). 26,001  individuals  were  recruited  for  this  study,  among  this  
25,455  individuals  participated  in  this  study  in  a  response  rate  of  97.9%. 
Prevalence  of  depression  was  assessed  by  using  Patient  HealthQuestionnaire 
(PHQ) - 12:  a  self – reported  questionnaire, and  found  that,  the  overall  
prevalence  of  depression   was  15.1%,  among  this,  the  prevalence  of  
depression  was  higher  in  females (16.3%)  than  in  males (13.9%). 
Chandran44  et  al, 2002  conducted  a  study,  to  estimate  prevalence  of  
depression  among  rural  and  low  socio  economic  status  women (359  
participants)  and  found  that  overall  prevalence  of  depression  among  them  
was  11%. Biswas45 et al, 2009;  conducted  a  door   to  door  survey  to  estimate  
the  prevalence  of  depression  in  an  elderly  individuals (204  participants)  and  
found  that  the  prevalence  of  depression  among  them  was  31.5% 
In  a   study  of  Amit Raval46,  et al,  and  his  colleagues  at  Chandigarh, 
India; 2010,  they  conducted  a  study  to  estimate  the  prevalence  and   
determinants  of  depression  among  type 2  diabetic  patients  and  found  that,  
among  300  type 2  diabetes  mellitus  patients (147 male  patients  and 153 female  
patients ),  68  patients  (23%) met the criteria for major  depression, 54   patients 
(18%) for  moderate  depression  and  the remaining 178  patients  (59%) had  no  
clinically  significant  depression. They  also  found  that  the  age  of  onset,  
duration  of  diabetes,  obesity,  glycemic  control  and  the  diabetic  complications  
having  an  impact  in  the  causation  of  depression  in  type 2  diabetic patients. 
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In  a  recent  study  of  Nitin Joseph47, Bhaskaran  Unnikrishnan, 
Y.P.Ragavendhra Babu  M, Shashidhar Kotian, and Maria Nelliyanil  et  al, 2013;  
they  conducted  a  study  to  estimate  the  proportion  and  determinants  of  
depression  in  type 2  diabetic  patients  in various  tertiary  care  hospitals  at 
Mangalore,  South India. Among  the  230  type 2  diabetic  patients  (119  male  
patients,  111  female  patients ), 71  patients (30.9%)  met  the  criteria  of  
moderate  depression,  33  patients  (14.3%)  met  the  criteria  of  severe  
depression  and  the  remaining126  patients  did  not  have  any  clinically  
significant  depression. They  also  found  that,  the  older  age,  low  socio  
economic  status,  female  gender,  unskilled  & retired  employment  status,   
obesity,  daily  medications  and  the  complications  of  diabetes,  were  markedly   
associated  with  the  causation of  depression  in  type 2  diabetic  patients. 
 
THE  PREDICTIVE  FACTORS: 
The  predictive  factors  (Psychosocial  factors )  play  an  important  role  in  
the  etiology  of  depression  in  diabetic  patients.  Various  studies  demonstrated  
extensively  about  the  causal  relationship  of  depression  in  diabetic  patients  
and  the  list  of  factors  identified  are: 
Female  Sex:                              -  Nanjundappa G  et  al,  1986,  
                                                      Nichols  et  al,  2003,   
                                                      Goldney  RD48  et  al,  2004,  and  
                                                      Shaban49  et  al,  2006. 
 
 
 
31 
 
Low  Education:                        -  Anne  Ergum  et  al,  2005. 
 
Lack  of  Social  support:           - De Groot50  et  al,  1999. 
 
Duration  of  Diabetes:               - Talbot51  et  al,  1999. 
 
Un - employment:                       - Mary  de  Groot52  et  al,  2007. 
 
Poor  Glycemic  control:             - Lustman53  PJ  Anderson  et  al, 2001. 
 
These  studies  indicated  the  consistent  findings  of;  female  sex,  low  
socio  economic  status,  low  education,  un-employment,  lack  of  social  support, 
uration  of  diabetes  and  the  poor  glycemic  control  have  a  significant  
association  with  depression  in  type 2  diabetic  patients. 
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ANXIETY:  A  VIGNETTE 
All  of  us  have  experienced  the  anxiety  symptoms  may  be  suffer  from  
particular  phobia,  a  little  obsessive  in  certain  things,  but  for  a  definite  
diagnosis,  it  should  be  clinically  significant,  must  be  severe  enough  to  cause  
significant  distress,  and  or  it  must  be  markedly  interfere  our  day – to – day  
lives  and  socio occupational  functioning. 
 
Anxiety  is  a  state  which  has  many  effects.  It  influences  the  cognition  
and   produce  the  perceptual  distortions.  There  is  a  difference  between  fear  
and  anxiety.  In  fear,  there  is  an  appropriate  response  to  a  known  threatening  
stimuli,  where  as  in  anxiety  there  is  also  a  response  to  a  threat  which  is  
not  known,  not  certain  or  disagreeable. 
 
Most  of  the  symptoms  of  anxiety  are  dreadful  which  are  accompanied  
with  somatic  complaints  and  autonomous  nervous  system  hyperactivity  such  
as  tachycardia,  palpitation,  sweating,  dry  mouth, etc.,.  Anxiety  also  
accompanied  with  psychological  symptoms  such  as  feeling  of  dread,  
difficulty  in  concentration,  insomnia,  decreased  libido,  lump  in  the  throat 
(Globus  Hystericus )   and  stomach  upset (Butter  flies). 
 
DSM-IV  eliminated  the  term “ Neurosis”  in  its  diagnostic  manual,  but  
still  it  is  retained  in  the  ICD – 10,  as  Neurotic,  stress  related  and  
somatoform  disorders (F 40 – F 48). 
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It  may  be  convenient  to  divide  the  anxiety  and  stress  related  disorders  
in to  3  categories,  because  of  the  acceptable  quality  of  the  symptoms  in  
each category. 
 
1.The  common  neuroses: 
    Anxiety / Panic  disorders;     e.g.  Panic  disorder, 
                                                           Agoraphobia, 
                                                           Generalized  Anxiety  Disorder, 
                                                           Specific  Phobia, 
                                                           Social  Phobia, 
                                                           Hypochondriasis.  
                                                          (Illness  anxiety  disorder  in  DSM 5) 
 
   Stress  related  disorders:  e.g.  Acute  stress  reactions, 
                                                     Adjustment  disorders,  
                                                      Post  Traumatic  Stress  Disorder (PTSD). 
 
   Obsessive  compulsive  disorders (Separate  entity  in  DSM – 5)  
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2.  The  Unusual  Neuroses:  (i.e. out  with ‘ normal’  experience) 
Anxiety / Phobic  disorders  e.g. “ non – understandable”  phobias (e.g.  dirt,  
                                                       feathers), Dysmorphophobia. 
     Hysterical  conversion  disorder, 
     Dissociate /Depersonalization – Derealization  disorders, 
     Somatoform  disorders. 
 
3. “Culture  specific”  disorders: 
      Chronic  fatigue  syndrome / Eating  disorder,  
      Other  “culture  bound”  disorders. 
 
ANXIETY  IN  DIABETES  MELLITUS 
 
CAUSES  OF  ANXIETY: 
Anxiety  disorders  are  common  and  more  prevalent  in  the  general  
population.  In  a  data  derived  from  multiple  community  surveys,  anxiety  
disorder  having  a  lifetime  prevalence  of  14.6%. When  compare  to  other  
mental  disorders   its  prevalence   is  high;  Schizophrenia (1 – 1.5%),  Affective  
disorders (8.3%),  and  substance  abuse  disorders (16.4%). 
 Anxiety  disorders  may  occur  spontaneously  or  in  association  with  
chronic  illnesses  like  Diabetes,  Hypertension,  Cancer, etc.,. The  anxiety  
disorder  in a  diabetic  patients  have  an  exaggerated  psychological  reactions  
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(misinterpretation of  bodily  cues) which  reflects as  anxiety  symptoms  in  an   
inappropriate  manner  as  harmful,  dreadful,  and  dangerous. This  in turn  lead   
to  an  increased  anxiety  and  fear (Grigsby  et  al,2001). 
 
PSYCHO PHYSIOLOGY OF  ANXIETY 
Anxiety  is  a  normal  and  adaptive  response  to  an  unknown  threat,  
which  makes  us  for  flight  or  fight. These  flight  or  fight  reactions   are  
mediated  by  the  interactions  of  both  sympathetic  and   para - sympathetic  
divisions  of  the  Autonomic  Nervous  System (ANS), which  results  in  increase  
somatic  and  autonomic  activity. 
 
Anxiety  is  said  to  be  an  abnormal,  when  it  is  present  in  an  excessive 
and  inappropriate  to  the  time  and  situation  with  regard  to  an  unknown  
threat. Anxiety  is  said  to  be  a  pathological  anxiety,  when  there  is  a  strong  
subjective  feelings  accompanied  with  physiological  activation,  which  lead  to  
trembling,  twitching,  feeling  shaky,  muscle  tension,  shortness  of  breath,  
hyper  ventilation,  exaggerated  startle  reflex  and  also  accompanied  with  
autonomic  hyperactivity  features  like  flushing,  tachycardia,palpitation,sweating,  
cold  hands,  diarrhea, dry  mouth  and  urinary incontinence. 
NEUROCHEMICAL  BASIS  OF  ANXIETY 
Alexander  Neumeister  proposed  that, there  is  a  specific  neurochemicals  
i.e.neurotransmitters   and  neuropeptides  in  the  brain  involved  in  the  initiation   
of  fear  and  anxiety  symptoms  in  response  to  a  threat  which  is  not  known,   
not  certain  or  disagreeable. During  a  stressful  condition,  either  an  acute  
36 
 
 threatening  situations  or  in  a  chronic  stress  like  chronic  illnesses,  these   
neurochemicals  released  from  the  brain  area  and  significantly  alters  the   
functions  of  that  brain  areas. 
 
NEUROTRANSMITTERS: 
 
There  are  three  major  neurotransmitters  identified  in  association  with  
anxiety  on  the  basis  of  animal experiments  and  also  with  the  drug  response  
to  the  drug  treatment. The  major  neurotransmitters  are; Norepinephrine,  
Serotonin,  and  Gamma Amino Butyric Acid (GABA). 
 
The  long  term  symptoms  of  anxiety  disorder  experienced  by  the  
patient  such  as  panic  attacks,  autonomic  hyperactivity,  increased  startle  reflex  
and  insomnia  are  the  characteristic  of  elevated  Norepinephrine  action. In  
general,  the  affected  persons  with  anxiety  may  have  a  dysregulation  of  
noradrenergic  system.  
 
   Studies  on  primates  showed  that,  stimulation  of  the  Locus  ceruleus 
produces  a  fear  and  anxiety  responses  in  animals. An  elevated  levels  of  
noradrenergic  metabolite  3 – Methoxy – 4 – Hydroxy  Phenyl  Glycol (MHPG) is  
found  in  the  cerebro spinal  fluid (CSF), and  in  the  urine  of  the  patients  with  
panic  disorder,  which  is  also  confirmed the  increased  norepinephrine  activity. 
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SEROTONIN: 
Clinical  studies  on  serotonin  function  in  anxiety  disorders  have  a  
variable  results. One  study  found  that  there  is  a  lower  level  of  circulatory  
serotonin  in  a  patients  with  panic  disorder,  when  compare  to  a  control  
group.In  general, the  anxiety  affected  persons  may  have a  dysregulation  of  
serotonergic  system,  which  is  evidenced  by  the  drug  response  of  SSRIs to  a  
panic  individual. 
 
GABA: 
GABA  is  an  inhibitory  neurotransmitter  that  inhibits  the  Central  
Nervous  System (CNS)  irritability  and  is  present  as  wide  spread  throughout  
the  brain. In  anxiety  disorder,  there  is  a  decreased  levels  of  circulating  
GABA  which  in  turn  lead  to  CNS  hyperactivity. The  action  of  GABA in  
anxiety  disorder  is  most  intensely   evidenced  by  the  Benzodiazepines,  which  
act  on  GABAA -  receptor  and  enhance  the  GABA  activity.Recent  studies  
also  suggests  a  role  of  neuropeptides  (Substance – P,  CRF, Cholecystokinin)  
and  an  aminoacid  neurotransmitter  Galanin  are  associated  with  the  anxiety  
disorder. 
 
HPA  AXIS  (Hypothalamo – Pituitary – Adrenal  Axis): 
 
There  is  an  elevated  synthesis  and  release  of  cortisol  evidenced  with  
many  forms  of  psychological  stress. Cortisol  contributes  to  increased  arousal,  
vigilance,  memory  formation  and  focused  attention.  Also,  cortisol  alters  the  
immune  mechanisms  and  it’s  responses. Cortisol  has  an  important  regulatory  
effects  on  prefrontal  cortex,  amygdale,  and  on  the  hippocampus. There  is  an  
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alteration  in  HPA –Axis  function  have  been  demonstrated  in  anxiety  
disorders  like  Post  Traumatic  Stress  Disorder (PTSD). 
 
CORTICOTROPIN  RELEASING  HORMONE (CRH): 
 
The  adaptive,  behavioral,  and  psychological  changes  occur  during  
stress  are  usually  coordinated  by CRH. It  is  one  of  the  most  important  
trigger  for  stress  response. Stress  induces  increased  levels  of  hypothalamic  
CRH,  which  in  turn  results  in  stimulation  of  HPA  axis  lead  to  excessive   
release  of  cortisol. 
 
APLYSIA: 
 
A  nobel  prize  winner, Dr. Eric  kandel  demonstrated  a  neurotransmitter  
model  for  anxiety  disorder. He  conducted  a  study  on  a  sea  snail –Aplysia 
Californica   and  found  the  varied  responses  to  dangerous  stimuli,  and  also  it  
responses  even  in  the  absence  of  stimuli  by  classical  conditioning.  
   
PSYCHO  DYNAMIC  MODEL: 
 
According  to  Freud,  unconscious  impulses (i.e.  Sex  or  Aggression)  
threaten  to  burst  in  to  the  consciousness  and  produce  an  anxiety. Anxiety  is  
related  to  childhood  fears  of  disintegration  which  derive  from  the  fear  of  an  
actual  loss  or  imagined  loss  of  loved   object  or  the  fear  of  bodily  harm (e.g.  
castration  anxiety). Freud  used  the  term  “Signal  Anxiety” -  to  describe  
anxiety  which  experienced  unconsciously  and  use  defense  mechanisms  to  
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deal  with  the  threatening  situation. For  example; The  various  defense 
mechanisms  used  in  the  anxiety  disorders  are; In  Phobia; Displacement,  
symbolization. Agoraphobia;  Projection,  Displacement.  OCD; Isolation  of   the  
affect,  Reaction  formation, Undoing.  Generalized  anxiety;  Regression.  Panic;  
Regression.  and   in  PTSD;  Regression, Repression,  Denial,  and  Undoing. 
 
LEARNING  THEORY 
 
Anxiety  may  be  learned  through  imitation  and  identification  of  anxiety   
patterns  from  their  parents – Social  Learning  Theory. Anxiety  is  stimulated  by   
a  natural  frightening  stimulus  like  an  accident,  which  lead  to  displacement   
or  transference  to  another  stimulus  by  a  conditioning  process,  that   produces   
a  phobia  to  a  new,  different  object  or  situation. 
 
Continued  or  severe  frustration  or  stress  produces  anxiety,  then  it  
become  a conditioned  response  to  other  less  severe  frustrating,  stressful  
situations.  In  diabetic  patients,  they  have  a  faulty,  distorted  patterns  of  
cognitive  thinking  which  was  learned  from  their  parents  which  in  turn  lead  
to  an  anxiety. 
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GENETIC  STUDIES: 
 
Hereditary  has  been  accepted   as  a  predisposing  factor  in  the  
development  of  anxiety  disorders. Almost  50%  of  the  panic  disorder  patients  
have  at least  one  affected  relative. Twin  studies  shows  that,  anxiety  disorders  
are  at least partially,  genetically  determined. About  5%  of  persons  with  high  
levels  of  anxiety  have  a  polymorphic  variant  of  genes  that  associated  with  
the  serotonin  transporter  metabolism. 
 
In  2005,  the  nobel  prize  winner  Dr. Eric  Kandel  found,  a  knocking   
out  a  gene  in  mice  brain. That  gene  codes  for  “Stathmin” – a  protein  that 
is  critical  for  the  amygdale  to  form  fear  memories. The  ‘Stathmin’  knock out  
mice  shows   anxiety  in  lesser  degree. 
 
PREVALENCE  OF  ANXIETY  DISORDERS  IN  DIABETES MELLITUS: 
Most  of  the  studies  in  Diabetes  focus  on  the  psychiatric  disturbance  
of  depression,  where  as  only  few  studies  demonstrated  the  anxiety  disorders 
in  Diabetes  mellitus  patients. 
 
Kaufman54  et  al,  Roy A  et  al,  demonstrated  that,  the  co - morbid  
Anxiety  disorder  with  Diabetes  lead  to  a  symptom  severity  and  persistence  
of  symptoms  and  greatly  impair  the  individual  role  in  the  social  and  
occupational  milieu.Most  of  the  studies  about  anxiety  in  diabetic patients,  
estimated  the  prevalence  of  anxiety  in  both  type 1  and  type 2  diabetes  
mellitus (Lloyd55  et  al, 2000;  Grigby56  et  al, 2002;  Hermanns57  et  al, 2005; 
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Barker  et  al, 2008). Janet  Thomas58  et  al, 2003,  demonstrated  the  association  
of  anxiety  disorders in  type 2  diabetes  mellitus  patients. In  this  study,  a  
structured  diagnostic  interview  method  like  DIS – DSM IV (Diagnostic  
Interview  Schedule  for  DSM – IV)  was  used. 
Various  scales  were  utilized  to  assess  the  anxiety  disorders  in  diabetic  
patients. HADS – (Hospital  Anxiety  and  Depression  Scale)  was  used  in  
Shaban MC59 et  al,2006,  Lloyd  et  al, 2000. Beck  Anxiety  Scale  was  used in  
Lloyd  et  al, 2003  study. In   Harmanns  et  al,2005, State  Trait  Anxiety  
Inventory (STAI)  and  Composite  International  Diagnostic  Interview(CIDI) 
were used  to  estimate   the  prevalence  of  anxiety  among  diabetic  patients.  
Grisby  et  al, 2001,  conducted  a  systematic  review  on  18  studies  
regarding  the  prevalence  of  anxiety  disorders  in  an  adult  population  with  
diabetes. He  found  that,  the  symptoms  of  anxiety  was  present  in  about  40%  
of  the  diabetic  patients. Also, he  found  that  there is  an  significantly  elevated  
anxiety  symptoms  present  among  female  diabetic  patients (55.3%)  than  the  
male  diabetic  patients (32.9%). Also, he  found  that there  is  an  increased  
symptoms  of  anxiety  present  among  type 2  diabetic  patients (42.2%)  than  
with  type 1diabetic  patients (41.3%). Among  the  40%  of  diabetic  patients  
presented  with  anxiety  symptoms,  while  applying  definite  diagnostic  criteria  
only  14%  of  the  diabetic  patients  were  qualified  for  the  definite  diagnosis  
of  Anxiety  disorders. 
 
Barker  et  al, 2008,  found  that  the  overall  life  time  prevalence  of  
anxiety  disorder  among  diabetic  patients  was  19.5%,  when  compare  to  the  
non – diabetic  individuals(10.9%). 
 
42 
 
Harmanns57  et  al, 2005,  carried  out  a  study  to  estimate  the  prevalence  
of  anxiety  symptoms  in  a  secondary  care  clinic  and  found  that,  19.3%  of  
the  diabetic  patients  had  anxiety  symptoms  and  5.9%  of  them  were  fulfilling  
the  criteria  of  anxiety  disorders. 
 
Lloyd55  et  al, 2000,  demonstrated  that  28%  of  the  participants  had  
moderate  to  severe  levels  of   anxiety  or  depression  or  both. Shaban  et  al, 
2006,  found  that  36%  of  the  study  participants  had  anxiety  symptoms,  and  
also  found  that ,  there is  an  elevated  severe  anxiety  symptoms  present  among  
female  diabetic  patients. 
 
Janet  Thomas58  et  al, 2003,  conducted  a  comparative  study  in  a  
primary  care  patients   who  were  diagnosed  as  type 2  diabetes  mellitus,  to  
evaluate  the  12  months  prevalence  of  depression  and  anxiety. A Structured  
Diagnostic  Interview  for  DSM – IV  was  used  to  assess  the  depression  and  
anxiety  and  found  that  11.7%  of  the  T2DM  patients  had  anxiety  disorders  
and  13%  of  the  T2DM  patients  had  mixed  anxiety  and  depression  disorder. 
This  study  shows  that,  type 2  diabetes  mellitus  increases  the  probability  of  
acquiring  anxiety  symptoms  by  an  Odds  ratio  of  2.26. (1.28 – 4.01, p 
value;0.005). 
In  a  recent  study,  Carlos Tovilla-Zarate 60,  et  al,  and  his  colleagues  at  
2012, conducted  a  study  to  estimate  the  prevalence  of  anxiety  and  depression  
among  T2DM  patients  in  an  outpatient  setup  in  the  Mexican  population. 
Hamilton  Anxiety  Rating  Scale  was  used  to  estimate  the  prevalence  of  
anxiety  and  found  that,  among  820  participants,  the  prevalence  of  anxiety  
was  55.10% (95%  CI;44.48 – 52.06)  and  also  found  that,  occupation  and  
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diabetic  complication  were  the  associating   factor  for  anxiety  in  type 2  
diabetic  patients. 
 
In  a  recent study  at  Malaysia,  Kurubaran  Ganasegeran61  et  al, 2014, 
demonstrated  the  factors  connected  with  depression  and  anxiety  among  type 
2  diabetic  patients. They  conducted  a  descriptive   cross – sectional  study  in  a  
single  centre  and  found  that,  among  169  T2DM  patients (men, n=99; women, 
n=70),   anxiety  present  in  53  patients  (31.4%). 
 
Multivariate  analysis  of  this  study  shows  that,  the  age  of  onset,  
ethnicity, monthly  income  and  the  complications  associated  with  diabetes  
mellitus  were  significantly  associated  with  the  causation  of  both  depression  
and  anxiety  among  the  type 2  diabetic  patients. 
  
Khuwaja62 AK,  et  al ,  and  his  colleagues  at  2010, conducted   a  multi – 
centre  study  at  Karachi,  Pakistan,  to  evaluate   the  prevalence  of  anxiety  and  
depression  among  T2DM  patients  and  found  that,  among  the  889  
participants  57.9%  of  the  type 2  diabetic  patients  had  anxiety  symptoms 
(95% CI = 54.7%, 61.2%). 
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THE  PREDICTIVE  FACTORS  RELATED  WITH  ANXIETY  IN 
TYPE 2  DIABETES  MELLITUS 
 
Various  studies  demonstrated  the  part  of  action  as   psychosocial  factors  
in  the  causation  of  anxiety  in  type  2  diabetic  patients. The  predictive  factors  
associated  with  anxiety  in  diabetes  are, 
 
Female  Sex:                              -  Grigsby  et  al, 2002, 
                                                       Hermanns  et  al, 2005, 
                                                       Shaban  et  al, 2006,  
                                                       Fisher63  et  al, 2008. 
 
Low  Education:                          - Janet  Thomas  et  al, 2003,  
 
Younger  Age:                             - Hermanns  et  al, 2004,  
                                                       Baker  et  al, 2008,  
                                                       Fisher  et  al, 2008,   
Type 2  Diabetes:                        - Janet  Thomas  et  al, 2003, 
                                                       Hermanns  et  al, 2005, 
 
 Poor  Metabolic  control:            - Kruse64 J et  al, 2003.  
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Various  studies  found  that  female  sex  as  a  significant  predictive  factor  
for anxiety,  few  studies like  Janet  Thomas  et  al, 2003, and Baker  et  al, 2008, 
failed  to  validate  that  finding. 
 
These  studies  indicated  the  findings  of;  female  sex,  low  socio  
economic  status, low  education, un-employment,  lack  of  social  support,  
duration  of  diabetes  and  the  occupational  stress   have  a  significant  
association  with  anxiety  in  type 2  diabetic  patients. 
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 SEXUAL  DYSFUNCTION:  A  VIGNETTE 
Sexual  dysfunction  is  a  major  health  care  problem  and  has  been  
neglected  for  many  years. Sexual  problems  are  under – recognized  and  under 
– diagnosed  even  among  clinicians,   due  to  lack  of  knowledge,  regarding  
handling  the  clients  with  sexual  problems. 
 
Based  on  patient’s  view,  a  sexual  problem  arises  when  an  individual   
presents  with  the  complaint  about  one  or  more  behavioral,  emotional  
(Affective  aspects)  or  perceptual  and  intellectual  (Cognitive  aspects  of   
mental  functioning)  problems  in  the  individual’s  sexual  relationship  or   
functioning. 
 
In  1966,  Master  and  Johnson65  described,  EPOR  model  of  sexual  
cycle,  which  included  4  phases  of  sexual  response  cycle;  Excitement,  
Plateau, Orgasmic,  and  Resolution. 
 
Later  in  early  1970,  Kaplan  proposed  the  DEOR  model  of  sexual  
cycle,  which  included  a  4  successive  phases  of  sexual  response  cycle;Desire,  
Excitement (Arousal),  Orgasm,  and  Resolution.Based  on  these  sexual  cycle,  
“Sexual  dysfunction”  was  referred  as  a problem  anyone  of  the  phase  in  the  
sexual  response  cycle,  which  stops  the  individual  or  couple  to  experiencing  
satisfaction  during  sexual  activity. 
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PSYCHO  SEXUALITY:     
This  term  is  usually  used  to  describe  the personality  development   and  
functioning,  because  these  are  usually  affected  by  sexuality. Psychosexuality  
is  not  merely  synonymous  with  Freudian  libido,it  applies  more  than  sexual  
feelings  and  sexual  behavior. 
 
Psycho  sexuality  involves  4  factors; 
 
(i)  Sexual  Identity:  A  pattern  of  an  individual’s  biological  primary  and   
                                    secondary  sexual  characteristics. 
 
(ii)  Gender  Identity:  An  individual’s  sense  of  being  a  male  or  female  
                                      which  is  usually  established  within  2 – 3  years  of  age. 
 
(iii)  Sexual  Orientation:  An  individual’s  sexual  impulses  towards  an  object;  
                                             Hetero  sexual  (Opposite  sex);  Homo  sexual (Same  
                                             sex);  or  Bisexual  (Both  sexes). 
 
(iv)  Sexual  Behavior:  Desires,  fantasies,  partner’s  pursuit,  autoerotism,  and  
                               the  various  activities  performed  to  satisfy  the  sexual  needs. 
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Levine SB66  et  al, 1989,  demonstrated  that,  an  adult  sexuality  has  an  unique 
seven  components; 
 
(i) Gender  identity,  
 
(ii) Orientation,   
 
(iii) Intention,  
 
(iv) Desire,   
 
(v) Arousal,   
 
(vi) Orgasm,  and   
 
(vii)Emotional  satisfaction. 
In  the  above  components,  the  first  3  components  comprises  the  sexual  
identity,  and  the  next  3  components  comprises  the  sexual  functioning. The  
seventh  entity,  the  emotional  satisfaction  is  based  on  the  above  first  6 
components.  
According  to  ICD – 10,  the  sexual  disorders  are  categorized  based  on  
sexual response  cycle; 
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Sexual  Desire  Disorders: 
                                              (i)  Lack  or  loss  of  sexual  desire,  
                                              (ii)  Sexual  aversion  and  lack  of  sexual  enjoyment, 
                                              (iii)  Excessive  sexual  drive. 
 
Sexual  Arousal  Disorders:  (i)  Failure  of  genital  response,  it  includes   
                                                   (a)  Female  sexual  arousal  disorder,  
                                                   (b)  Male  erectile  disorder,  
                                                   (c)  Psychogenic  impotence. 
 
Orgasmic  Disorders:         (i)  Orgasmic  dysfunction,   
                                              (ii)  Lack  of  sexual  enjoyment,  
                                              (iii)  Premature  ejaculation. 
 
Sexual  Pain  Disorders:    (i)  Non  organic  dyspareunia,  
                                             (ii)  Non  organic  vaginismus, 
 
The  Resolution  phase  sexual  disorder  are  added  in  DSM – IV TR. 
It  includes: 
                                             (i)  Post  coital  dysphoria,  
                                             (ii) Post  coital  headache. 
DIABETES  MELLITUS  AND  SEXUAL  DYSFUNCTION 
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SEXUAL  DYSFUNCTION  IN  MEN: 
Male  sexual  dysfunction  are  classified  into  dysfunctions  of  libido,  
problems  with  emission  or  ejaculation  or  orgasm,  impotence,  and  priapism. 
Erectile  dysfunction (ED)  or  impotence  is  the  most  common  of  the  various  
sexual dysfunctions  among  diabetic  men. Previously, ED was    believed  as  to  
be  a  psychogenic  origin,  even  when  it  is  associated  with  diabetes. But,  we  
now  accept  the  concept  that,  ED is  the  one  of  the  complication  of  diabetes  
mellitus  and  is  one  of  the  warning  sign  for  future  macro-vascular  
complications  like  myocardial  infarction. 
 
PHYSIOLOGY  OF  ERECTILE  FUNTION: 
 
Penile  tumescence  is  a  vascular  process   under  the  exclusive  control  of  
the  autonomic  nervous  system. Corpus  cavernosum  of  the  penis  acts  as  a  
erectile  tissue  and  behaves  as  a  sponge,  and  the  erection  occurs  when  it  
becomes  engorged  with  abundant blood  supply. The  dilatation  of  the  
arterioles  and  vasculature  bed  of  copus  cavernosum  leads  to  compression  of   
the  tunica  albuginea,  which  in  turn  prevents  the  outflow  of  blood  through  
the  venules. 
Thus,  smooth  muscle  relaxation  is  the  key  role  in  the  process  of  
erection, as  it  enhances  increased  arterial  blood  flow  and  decreases  the  
venous  outflow. These  process  is  exclusively  under  the  control  of  
parasympathetic nerve  fibres,  previously  it  was  considered  as  due  to  
noradrenergic,  and anti  cholinergic  neurons. 
Recently,  it is clear  that  NO (Nitric  Oxide)  is  the  agent  responsible  for  
smooth  muscle  relaxation  with  in  the  corpus  cavernosum. Nitric  oxide  is  
produced  both  by  parasympathetic  nerve  terminals  and  by   the  vascular  
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endothelium. The  nitric  oxide  stimulates  guanylate  cyclase  with  in  the  
smooth  muscle,  which  leads  to  increased  production  of  the  cGMP  (cyclic  
guanosine  mono  phosphate -  a  second  messenger)  which  in  turn  induces  the  
smooth  muscle  relaxation,  which  is  probably  due  to  opening  up  of  calcium  
channels.  
 
PATOPHYSOLOGY  OF  ERECTLE  DYSFUNCTON  IN  DIABETES: 
In  men  with  diabetes  mellitus,  there  is  an  evidence  of  erectile  
dysfunction  due  to  lack  of  nitric  oxide  induced  smooth  muscle  relaxation,  
which  is  due  to  diabetic  complications  of  both  autonomic  neuropathy  and  
vascular  endothelial  dysfunction. In  early  stages  of  diabetes,  many  men   
reports  that  they  do  not  have  an  erection  problem  initially,  but  they  
complaints  of  unable  to  maintain  the  erection. This  is  because  of  the  lack  of 
endothelium  derived  nitric  oxide, which  occurs  prior   to  the  significant 
autonomic neuropathy.  
Most  recently,  an  impairment  of  EDHF (Endothelium – Derived  
Hyperpolarizing  Factor)  was  detected,  which  is  essential  for  endothelium – 
dependent  smooth  muscle  relaxation. There  is  an  evidence  of  increased  
oxygen – free radicals  in  diabetes,  which  in  turn  reduces  the  nitric  oxide  
induced  vasodilator  effect. 
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OTHER  FACTORS  ASSOCIATED  WITH  ERECTILEDYSFUNCTION  IN 
DIABETES: 
 
In  addition  to  the  autonomic  neuropathy  and  vascular  endothelium   
dysfunction,  various  other  conditions  triggering  erectile  dysfunction  in   
diabetes,  like  hypertension  and  large – vessel  disease. 
 
Furthermore,  the  medications  taken  by  the  diabetic  individual  for  their  
allied complications  like  hypertension,  dyslipidemia,  antidepressants,  
antipsychotics, and  other  miscellaneous  drugs  can  worsen  the  erectile  
dysfunction. 
 
There  are  various  conditions  are  associated  with  the  erectile  
dysfunctionin  diabetes  mellitus  patients  and  many  of  them  are  the  potential  
cause  for erectile  dysfunction  in  diabetic  patients  like; Psychologic  disorders,  
like  as (Performance  Anxiety, Sexual  problems  in  the  partner, Psychological  
trauma  or  abuse,  Misconceptions), peripheral  arterial  disorders, Nervous  
system  damage (multiple  sclerosis,  CVA, spinal  cord  lesions), Endocrine 
abnormalities,  others  like,  high  blood  pressure,  smoking, etc.,.                          
                                                             
FEMALE  SEXUAL  DYSFUCTION  IN  DIABETES  MELLITUS: 
The  female  equivalent  of  male  erectile  dysfunction  is  the  reduced  
vasoconstriction  of  the  vulva  and  vagina,  which  lead  to  impaired  arousal  
and  decreased  vaginal  lubrications. Failure  to  achieve  an  erection  in  male  
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makes  sexual  intercourse  is  impossible,  but  the  decreased  vaginal  lubrication  
in  female  is  easily  managed  with  simple  treatments  with  lubricating  creams   
and  it  may  not  be  considered  as  an  abnormality  even  by  a  postmenopausal   
woman. 
 
The  vasoconstriction  in  female  genitalia  results  in  reduced  vaginal  
secretions,  and  the  lack  of  nitric  oxide  related  smooth  muscle  relaxation lead  
to  dryness  of  the  vagina  which  are  usually  followed  by  an  endothelial  
dysfunction  and  nervous  system  damage. 
, 
In  women  with  diabetes,  the  genitourinary  infections  is  a  common  
finding, especially  vaginal  candidiasis. Vaginal  cadidiasis   is  more  prevalent  
among diabetic  women  since  the  yeasts  thrive  well  in  a  glucose  rich  
environment,which  is  commonly  due  to  poor  glycemic  control. Severe  
genitourinary  infections  can  be  very  irritating  and  painful  and  further  it  can  
interfere  with  the  sexual  intercourse. 
 
PSYCHOLOGICAL  FACTOR  IN  SEXUAL  DYSFUNCTION 
PREDISPOSING  FACTORS: 
(i)  Disturbed  relationship,  
(ii)  Inadequate  sexual  knowledge,  
(iii)  Insecurity  in  the  psychosexual  role,  
(iv)  Traumatic  sexual  experience  in  early  life,  
(v)  Restrictive  upbringing,  
(vi)  Distractions (especially  in  females). 
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PRECIPITATING  FACTORS: 
(i)     Unreasonable  expectations (especially  males), 
(ii)     Discard  in  the  relationship,  
(iii)    Random   failure (males), 
(iv)    Dysfunction  in  the  partner,  
(v)     Depression  or  Anxiety,  Infidelity,  
(vi)    Poor  intimacy (emotional), 
(vii)   Child  birth (females),  
(viii)   Reaction  to  organic  disease,  
(ix)     Expecting  a  negative  outcome (females),  
(x)      Restricted  foreplay,  
(xi)     Performance  anxiety (males),  
(xii)    Guilt / fear  of  intimacy,  
(xiii)    Poor - communication,  
(xiv)    Poor - self  image,  
(xv)     Decreased  attractions  between  partners,  
(xvi)    Sexual  myths. 
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SEXUAL  DYSFUNCTION;  VARIOUS  STUDIES 
 
Sexual  dysfunctions  are  fairly  common  and   are  almost  equal  in  both  
the  sexes,  even  though  there  may  be  differences   in  seeking  help  in  
different  cultures  and  societies.(r) 
 
In  1970,  Masters  and  Johnson65  reported  that,  almost  50%  of  all  
Americans  have  sexual  problems  sometimes  during  their  life.(r)  In  1979,  
Gebhard  and  Johnson  proposed  that  an  occasional  erectile  failure  occurs  in  
about  35% of  males.(R). In  1959,  Bagadia67  and  colleagues  conducted  an  one  
of  the  first  literature  on  male  sexual  dysfunction  and  reported  that,  
ignorance,  fears,  guilty  feelings  and   superstitions  about  the  sex  are  the  
major  areas  of  concern. 
 
Further  in  1972,  Bagadia68  and  his  colleagues  conducted  an  another  
study  and  interviewed  about  258  male  out  patients  and  found  that,  the  
anxiety  on  nocturnal  emission  was  65%  and   semen  in  urine  was  47%  and  
concluded  that  these  were  the  main  problems  in  the  unmarried  group;  and  
also  concluded  that,  impotence  was  48%,  premature  ejaculation  was  34%  
and  passing  semen  in  urine  was  47%  among  the  married  group. 
 
They  also  found  that  diagnosable  psychiatric  conditions  were    common   
among  these  individuals  like  anxiety  state  (57%),  reactive  depression  (16%),  
and  schizophrenia  (16%)  in  that  sample.(r) 
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In  1977,  Nakra69  and  Wig  et  al,  conducted  a  study  in  a  medical  and  
psychiatric  OPD  and  found  that  10%  of  males  attending  these  OPD had 
sexual  problems. In 2008, Kendurkar70  et  al,  and  his  colleagues  reviewed  the  
data   of  1242  patients   in  a  period  of  1979 – 2005  and  concluded  that  the 
Premature  ejaculation  was  the  important  complaint  followed  with Erectile  
dysfunction  and  Dhat  syndrome. 
 
In  2009,  Singh71  et  al,  and  his  colleagues  conducted  a  cross – sectional  
study  and  surveyed  in  149  married  women  in  a  tertiary  care  hospital  and  
found  that,  female  sexual  dysfunction  reported   in  73.24%  of  the  
participants,  and  also  concluded  that difficulties  in  desire  was  77.2%,  
difficulties  in  arousal  was  91.3%,  difficulties  in  lubrication  was  96.6%  
difficulties  in  orgasm  was  86.6%,  difficulties  in  overall  satisfaction  was  
81.2%  and  the  pain  during  sex  was  64.4%.  They  also  found  the  contributing  
factors  of  women of  age  above  40  years,  and  low  education  and  the  
physical  illness  of  both, poor   intimacy were  attributed  to  the  female  sexual  
problems  and  none  of  them  sought  any professional  help. 
 
In  2007,  Kar,  Koola72  et  al,  conducted  a  study  and  found  that,  
28.62%  of women  had  orgasmic  difficulties   and  40%  of   them  reported  that,  
they never  masturbated. 
 
In  2008,  Avasthi73,74  et  al,  and  his  colleagues  conducted  an  interview  
in  100  women  those  attending  a  pediatric  OPD  for  their  children  in  a  
tertiary  care  hospital  and  found  that, 17%  of  them  had  difficulties  during  
sexual  activity,  which  includes  difficulty  in  orgasm  was  9%,  pain  during  
intercourse   was 7%,  poor  vaginal  secretion  was  5%,  dyspareunia   was  5%. 
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Among  the  17%,  the  individuals  attributed  these  difficulties  to  their  own  
health  related  problem  was  14%. 
   
SEXUAL  DYSFUNCTION  IN  DIABETES;  VARIOUS  STUDIES 
 
Feldman75  HA   et  al,  and  his  colleagues  at 1994, conducted  the  
Massachusetts Male  Aging  study  on  impotence  and  its  medical  and  
physiological  associations  and  found  that,  an  exclusive  prevalence of  
complete ED was  5%  in  men  in  their  40S  and  15%  in those  over  70  years. 
 
In  a  study  on  diabetic  patients  who  attending  a  diabetic  clinic  done  at  
UK, the  prevalence  of  erectile  function  increased  from  13%  amongst  30  year  
olds to  61%  amongst  men  aged  over  60  years;  overall,  the  prevalence  was  
38%. 
 
Hackett76 GI  et  al,1995,  conducted  a  study  and  concluded  that,  the  
prevalence  of   erectile  dysfunction  in  diabetes  in  a  general  practice  
population  was  reported   to  be  even  higher,  at  55%. 
Nicolosi77 A,  Glasser  DB, Moreira  ED, Villa M  et  al, 2003,  conducted  a   
population  study  to  estimate  ED  occurrence, and  they  surveyed  600  men  in  
various  countries   and  estimated ,  the  prevalence  of  ED  among  men  with   
diabetes  rose  from  25%  at  age  40 – 44  years  to  70%  at  age  65 – 70  years. 
 
They  also  found  that,  the  presence  of  other  medical  conditions  
increases  the  risk  of  erectile  dysfunction.   The  prevalence  of  an  erectile  
dysfunction  among  diabetic patients  was  31.7%  only,  which  increased  to  
40%  in  men  with  diabetes  and  heart  disease  and  46.5%  in  those  with  
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diabetes  and  hypertension. They  also  found  that,  the  prevalence  which  was  
increased  with  the  duration  of  diabetes  mellitus. 
 
Ma78  RC,  et  al,   and  his  colleagues  at  2008, conducted  a  study  to  find  
the association  of  erectile  dysfunction  in  type 2  diabetic  patients  and  
coronary  heart  diseases  and  found  that, there  is  an   increased  risk  of  
developing  heart disease  among  diabetic  patients  with  erectile  dysfunction  
than  without  erectile  dysfunction. 
 
Bacon79  CG,  and  his  colleagues   Mittleman  MA,  Kawachi I, 
Giovannucci E, Glasser DB,  Rimm EB   et  al, 2003, and  Feldman  HA,   with  
his  colleagues  et  al, 1994, found  that,  smoking   was  an   exclusive  factor  
which   almost  doubled  the  risk  of   developing  erectile  dysfunction   after  
about   7  years. 
 
Bacon79  CG,   and  his  associates et  al, 2006, found  that,  drinking  
alcohol  in  moderation  appears  to  reduce  the   risk  of  becoming  impotent. 
 
According  to  Craig80 A, et  al,1997, (one  in  ten, London: Impotence 
Association),conducted  a  survey  and  found  that,  depression  was  reported  in  
62%  of  men with  erectile  dysfunction. 
 
Hackett76 GI  et  al,1995,  conducted  a  study  and  found  that,  45%  of  
men  with  diabetes  thought  about  their  erectile  dysfunction  frequently,  23% 
had  the  feeling  of  poor  quality  of  life   and  10%  had  the  strong  feeling  of  
poor  enduring  connection   between  the  couples.. 
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Enzlin 81 et  al, 1998,  conducted  an  analysis  of  15  studies   carried  out  
in  female  sexuality  in  diabetes  from  1971,  and   concluded   that,  the  
occurrence of   poor  sexual  arousal  and  also  in  a  lack  of  vaginal  lubrication  
was  between  15%  and  45%  in  women,  which  was  markedly  higher  than  in  
women   without  diabetes.  
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AIMS  AND  OBJECTIVES  OF  THE  STUDY 
 
1. To  estimate  the  prevalence  of   depression,  anxiety   in  type 2  diabetes   
     mellitus  patients. 
  
2. To  assess  the  quality  of  sexual  (dys)functions  in  four  dimensions, 
     i.e.  psycho – somatic  quality  of   life (PSQoL),  sexual  activity,  sexual  
     dysfunction  – self - view,  and  sexual  dysfunction – partner-view  in  type 2 
     diabetes  mellitus  patients. 
                                   
3. To  compare  the prevalence  of   depression  and  anxiety  in  type 2   
    diabetes  mellitus  patients  with  age  related  non- diabetic  individuals. 
 
4. To  compare  the  quality  of  sexual  (dys)functions  in  four  dimensions  
    i.e.  psycho – somatic  quality  of   life,  sexual  activity,  sexual  dysfunction  
    – self - view,  and  sexual  dysfunction – partner-view  in  type 2  diabetes   
    mellitus  patients  with  age  related  non-diabetic  individuals. 
 
 5. To  evaluate  the  impact  of  Role  of  sexuality  and  menopause  status   
     on  the  quality  of  sexual  function. 
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HYPOTHESIS 
 
1.  Prevalence  of    depression  is  more  in  diabetic  patients  than  non – diabetic  
     individuals. 
 
2.   Prevalence  of    anxiety is  more in  diabetic  patients   than  non – diabetic  
      individuals. 
 
3.   The  Socio – Demographic    factors  are  significantly  influences   the   
      occurrence  of  depression  symptoms  and  anxiety  symptoms   in  type 2   
      diabetic  patients. 
 
4.   The  quality  of  sexual  (dys)functions  in  four  dimensions; 
     ( i.e.  psycho – somatic  quality  of   life (PSQoL),  sexual  activity,  sexual  
     dysfunction –  self - view,  and  sexual  dysfunction – partner-view)  are   
     significantly  affected  in  type 2  diabetes  mellitus  patients  than  age  related  
     non – diabetic  individuals. 
 
5.  Role  of  sexuality  and  menopause   influences  the  quality  of  sexual   
     function  in  type 2  diabetic  patients. 
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MATERIALS AND METHODS 
 
STUDY  POPULATION: 
 
 The  study  population  includes  of  patients  attending  as  out - patients  in  
 Department  of  Diabetology  and  the  attenders / relatives  who  accompanying   
 with  the  patients  attending  General  Medicine,  out –  patient department. 
 
CASE  GROUP: 
 
Diabetic  patients  who  registered  in  Department  of  Diabetology,  Govt.  
Stanley  medical   College  Hospital – by  applying  both  inclusion  and  exclusion  
criteria  and  about  80  patients (both  genders) - who  fulfil  the  criteria,  were  
selected  for applying  various  scales  to  assess  the depression,  anxiety,  and  
quality  of  sexual  (dys)functions  after informed  consent. 
 
CONTROL GROUP: 
 Age  matched  non – diabetic  individuals  selected  from  attenders / 
relatives  accompanying with  the  patients  attending  the   Medical  Out-patient  
Department.  About   80   controls  (both  genders) are  selected  and  compared. 
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METHOD OF COLLECTION 
 
1.  After  obtaining  informed  consent  from  patients  with  diabetes  attending  the   
     Diabetology  OPD,  they  will  be  interviewed  and  assessed  using  various   
     scales.  Data  will  be  recorded  for  this  purpose. 
2.  Information  is  obtained  from  patient,  reliable informant,  and  from  medical   
     records. 
3.  Socio – demographic  and  medical  details  will  be  obtained  using  a   
     questionnaire  designed  for  this  study. 
4.  Investigation reports from OP records. 
 INCLUSION CRITERIA 
 
1. Patients  diagnosed  as Diabetes  mellitus (based on ADA criteria)  in    
    Diabetology  Department. 
2. Age  > 30  years  and < 50 years   registered in  Diabetology   
    Department. 
3. Patients  of  both  genders  diagnosed  as  type 2  diabetes  mellitus  
   (minimum  duration  of  6  months). 
4.Consenting  age  related   non-diabetic individuals  accompanying  with   
    patients  attending    Medical  Out – patient department. 
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EXCLUSION CRITERIA 
 
1.  Co-morbid  physical  disorders:  hypertension,  alcoholic cirrhosis,   
           endocrine  disorders,  history  of  genitor – urinary  surgery  and   
           neurological  or  spinal  cord  lesions. 
 
2.  Past  or  present  history  of  any  mental  illness. 
 
3.  Patients  with  history  of  primary  sexual  dysfunction  prior  to  the   
            diagnosis  of   type 2  diabetes  mellitus. 
 
4.       Substance  use  disorders: alcohol  dependence,  cannabis  use  disorder. 
 
5. Use  of  drugs  affecting  sexual  function ( anti - psychotics, anti –  
        depresssants,  anti- hypertensives,  steroids,  fibrates,  etc.) 
 
MATERIALS  FOR  THE  ASSESSMENT 
1. Socio – demographic  pro- forma  sheet  designed  for  this  study. 
2. M.I.N.I - Mini International Neuropsychiatric Interview. 
3. Beck depression inventory (BDI). 
4. Hamilton rating scale for Anxiety (HAM-A).  
5. Quality of Sexual Function (QSF) Scale. 
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STUDY  DESIGN: 
 
The  study  subjects (Cases)  were  taken  from  the  Diabetology  
department  OP section,  at  Government  Stanley  Medical  College  Hospital. 
Those  who  fulfilled  the  criteria  of  both  inclusion  as  well  as  the  exclusion  
criteria  were  included  for  this  study. An  informed  consent  was  explained  and  
obtained  from  the  patients. A thorough  clinical  evaluation  was  done  to  find  
out  any  physical  complications,  psychiatric  illnesses,  any  drug  treatments,  
since  these  factors  are  the  confounding  factors  of  this  study. Patients  OP  
records  were  evaluated  to  obtain  a  glycemic  control  status, duration,  and  age  
of  onset. 
 
An  Age  matched  study  subjects (Controls)  were  taken  from  the  
General  Medicine  department  OP  section,  at  Government  Stanley  Medical  
College  Hospital. The  control  group  population   were  non – diabetic  
individuals    (attenders / relatives)  accompanying with  the  patients  attending  
the  General  Medicine  Out-patient  department. An  informed  consent  was  
explained  and  obtained  from  them. A thorough  clinical  evaluation  was  done  
to  find  out  any  physical  conditions,  psychiatric  illnesses,  any  drug  
treatments,  since  these  factors  are  the  confounding  factors  of  this  study.  
 
ASSESSMENT  PROCEDURE  OF  THE  STUDY:  
 
A  detailed  socio  demographic  details  like  age,  sex,  education,  religion,  
socio  economic   status, etc.,   were  recorded  in  the  semi – structured  pro -
forma  sheet  designed  for  this   study. Patients  and  as  well  as  the  non – 
diabetic  individuals  were  evaluated  clinically,  and  the  records  of  them  were  
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reviewed  thoroughly. Dibetologist  guidance  was  utilized  when  there  was  any  
doubt  regarding the  patient’s (Case)  disease  status. Those  who  fulfilled  the  
criteria  of  both  inclusion  as  well  as  the  exclusion  criteria  were  screened  
initially  by  M.I.N.I - Mini International Neuropsychiatric Interview,  then  the  
depression  was  assessed  with  BDI (Beck  Depression  Inventory),  anxiety  with  
HAM – A (Hamilton  Rating  Scale  for  Anxiety),  and  the  quality  of  sexual  
function  was  assessed  with  QSF (Quality  of  Sexual  Function)  Scale. 
 
M.I.N.I  (Mini International Neuropsychiatric Interview). 
 
The  M.I.N.I  (Mini – International  Neuropsychiatric  Interview)  is  
developed  by  psychiatrists  and  clinicians  jointly,  based  on  the  psychiatric  
conditions classified  in  DSM – IV,   and  in  ICD – 10. 
 
This  is  a  short  and  structured  screening  diagnostic  interview. The  time  
to  administrate  this  diagnostic  tool  is  approximately  fifteen  minutes. It  can  
be  used  as  a  potential  first  step  tool  for  the  screening  of  psychiatric  
disorders.It  was  designed for  the  clinical  trial needs  and  an  epidemiological  
study  needs  and   it  is  an  accurate  short  structured  psychiatric  interview  tool  
and  has  good  reliability  and  validity. 
 
Sheehan82 DV et  al, 1998,  and  his  colleagues  validated  this  diagnostic  
interview with  relation  to  SCID (Structured Clinical Interview for DSM-III-R),  
CIDI(Composite International Diagnostic Interview),  patients  version  and  an  
expert  clinician  opinion  and  they  recommended  that  M.I.N.I  is  an  potential  
tool  for  the  screening  psychiatric  disorders.   
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Beck’s  Depression  Inventory  (BDI): 
 
BDI83  is  the  one  of  the  most  important  self -  report  rating  scale  which  
is  a  gold  standard  tool  to  assess  the  depression  severity. BDI  was  developed  
by  Beck  et  al,  at  1961,  and  his  original  and  an  old  BDI  consists  of  21  
items,  which  concern  about  various  symptoms  with  varying  degrees  of  
severity  and  rated  the  scores  as  0 – 3. BDI85 – II  edition  was  released  after  
the  introduction  of  DSM – IV ,  which  included  some  new  items  and  
excluded  some  items  present  in  the  previous  scale,  and  make  it  more  
reflective  towards  DSM – IV. BDI86 – II consists  of  21  items,  with  a  total  
score  ranges  of  0 – 84. Scores  of  0 -10  considered  as  normal  mood  swings  
of  ups  and  downs; considered  as  normal,  the  according  to  the  scores,  
classified  as  mild  to  extreme  depression. BDI  was  used  in  various  studies  
because  of  its  high  reliability  and  consistent  validity,  and  also  the  internal  
consistency  of  this  scale  is  higher. Since  this  scale  is  having  the  advantage  
of  time  consumption,  patient  self  reporting  model,  and  the  easy  scoring  of  
the  severity  make  it  a  gold  standard   tool  to  assess  the  severity  of  
depression. 
 
The  Hamilton  Rating  Scale  for  Anxiety87  (HAM-A): 
This  rating  scale  is  administered  by  the  clinician,  and  it  is  basically  a  
semi – structured   type  to  evaluate  the  anxiety  symptoms. This  scale  evaluates  
symptoms  alone  and  not  for  any  specific  disorders. It  is  one  of  the  rating  
scale  developed  first  to  assess  the  severity  of  the  symptoms. Still,  it  is  used  
for  clinical  studies  and  for  research  purposes,  because  of  it’s  high  reliability  
as  well  as  it’s  high  validity.  It  also  yields  a  high  consistency. This  scale  is  
also  used  in  the  drug  trials  for  the  quantifying  the  outcome,  in  Generalized  
anxiety  disorder.(88,89) 
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This  scale  consists  of  fourteen  entities,  each  of  the  entity  is  graded  as  
0  to  4 (not  present  to  severe),  higher  the  scores  more  severe  in  the  anxiety  
symptoms. The  total  score  is  ranges  from  0 – 56,  and  the  scores  < 17  
indicates  mild  severity,  scores  between  18  and  24  indicates  mild  to  
moderate  severity,  scores  between  25  and  30  indicates  moderate  to  severe  
anxiety  symptoms,  and  the  total  scores  more  than  30  indicates  very  severe.  
 
HAM – A  scale  is  a  simple  scale  easy  to  administer  within  20  to  30  
minutes90. It  is  useful  to  monitor  the  improvement  after  initiation  of  drug  
treatment. This  scale  was  translated  in  various  languages,  because  of  it’s  
acceptable  inter – rater  reliability. 
     
QUALITY  OF  SEXUAL   FUNCTION  (QSF)  QUESTIONNAIRE: 
 
The  QSF  is  self-report  questionnaire  developed  by  Heinemann91  et  al. 
in  2005 and  contains  of  40  items,  which  include  32 items  specific  to  4  
domains  and  8  general  questions . The  four  Domains  are  psycho-somatic  
quality  of  life  (QOL),  13  items;  sexual  activity (ACT),  7  items; sexual 
(dys)function-self- reflection (SDFS),  7  items;  and  sexual (dys)function-
partner's  view  (SDFP),  5  items.  The  QSF  mainly  uses  a  five-point  scale  (1-
5);  some  items  in  sexual  activity,  sexual (dys)function – self – view,  and  
sexual (dys)function – partner's  view  domains  use  a  six-point   scale (0-5) with  
the  values. 
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The  final  score  is calculated  by  adding   the  score  of  all  items  in each   
domains. The  severity  of   complaints  or  problems   rises  as  the  total   score    
increases. 
The  score  entered   in  the  QSF  scale  was simply  adding  up  to  each  
domains  according  to  scoring  points.  Sum  of  scores  were  classified  into  four  
categories  of  complaints  or  problems; no/little,  mild,  moderate,   and  severe 
according  to  the  scoring  points. 
QSF – Scoring  details: 
Psychosomatic  Quality  of  life: 
≤  15     ; no,  little, 
16 – 24;  mild, 
25 – 34;  moderate, 
≥  35    ;  severe. 
 
Sexual  activity  level: 
≤ 17      ; no,  little, 
18 – 23 ;  mild, 
24 – 26;  moderate, 
≥ 27     ; severe. 
 
Sexual  (dys) function – Self  view: 
≤  9      ;  no,  little, 
10 – 15;  mild, 
16 – 19;  moderate, 
≥ 20     ;  severe. 
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Sexual  (dys) function – Partner  view: 
≤  5     ;  no,  little, 
6  –8   ;  mild, 
9  – 11;  moderate, 
≥ 12    ;  severe. 
 
QSF (Quality  of  Sexual  Function)  Total  Score: 
≤  54     ; no,  little, 
55 – 68;  mild, 
69 – 79;  moderate, 
≥  80    ;  severe. 
 
QSF  Scale  is  easy  to  understand,  and  takes  a  lesser  time  to  complete,  
and  an  easy  tool  to  measure  the  sexuality  as  well  as  the  quality of life  in  a  
same  time  and  translated  in  many  languages92. It  can  be  used  in  both  
genders  with  an  easy  to  evaluate. The Cronbach’s  alpha  coefficient  of  QSF  
was  0.8. QSF  Korean93 (QSF – K) version  was  made   recently (J Korean Med 
Sci. Jun 2014; 29(6): 758–763)   which  was  evaluated  by  test – retest  procedure  
and  found  that, intra-class correlation coefficients (ICC)  value  to the  total  QSF 
– K  was  0.70  (Items  Range; 0.52 – 0.70), and  the  Korean  QSF - Cronbach's 
alpha coefficient was 0.83.  (Range;   0.61 - 0.90).Since,  the  Tamil  version  is  
not  available,  we  translated  the  QSF  English  version  to  Tamil  and  asked  the  
social  psychologist  and  as  well  as  clinical  psychologist   to  evaluate,  translate   
and  back  – translate   to  English. Also, this  scale  was  applied  in  both  in  
Tamil  as  well  as  English  version,  both  gives  us  the  same  results  in  a  same  
patient.     
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STATISTICAL ANALYSES 
 
Statistical analysis will be done using computerized software (SPSS-20).  
Descriptive statistics like frequencies, percentages, means and standard deviations  
will be computed. Parametric and non parametric analysis will be used  
appropriately depending on the data collected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
 
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATIONS  AND  RESULTS 
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              TABLE – 1. AGE  DISTRIBUTION 
AGE * GROUP  
   GROUP Total 
   CASE CONTROL 
AGE 31-35 YRS Count 16 16 32 
% within GROUP 20.0% 20.0% 20.0% 
36-40 YRS Count 19 19 38 
% within GROUP 23.8% 23.8% 23.8% 
41-45 YRS Count 22 22 44 
% within GROUP 27.5% 27.5% 27.5% 
46-50 YRS Count 23 23 46 
% within GROUP 28.8% 28.8% 28.8% 
 Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
                                                  
 
In  this  study  cases  and  age  matched  control  groups  included  were, in  
31 – 35 age group ;16 cases,  16  controls,  in  36 – 40  age group; 19cases ,  
19 controls,  in  41 – 45  age  group; 22  cases,   22  controls ,  in  46 – 50  age   
group; 23  cases ,  23  controls.                                                                                                                                                   
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TABLE -2. SEX  DISTRIBUTION 
SEX * GROUP  
   GROUP Total 
   CASE CONTROL 
SEX MALE Count 54 54 108 
% within GROUP 67.5% 67.5% 67.5% 
FEMALE Count 26 26 52 
% within GROUP 32.5% 32.5% 32.5% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
 
Among  80  cases  54  were  males,  and  26  were  females  and  an 
equivalent  number  of  controls  were  included  in  this  study. 
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TABLE -3. EDUCATION  DISTRIBUTION 
EDUCATION * GROUP  GROUP Total 
   CASE CONTROL 
EDUCATIO
N 
ILLITERATE Count 5 9 14 
% within GROUP 6.2% 11.2% 8.8% 
PRIMARY Count 16 12 28 
% within GROUP 20.0% 15.0% 17.5% 
MIDDLE Count 26 25 51 
% within GROUP 32.5% 31.2% 31.9% 
HIGH SCHOOL Count 19 18 37 
% within GROUP 23.8% 22.5% 23.1% 
UG Count 12 13 25 
% within GROUP 15.0% 16.2% 15.6% 
PROFESSIONAL Count 2 3 5 
% within GROUP 2.5% 3.8% 3.1% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
     
 
 
Among  education  status  illiterate ;5  cases, 9 controls; primary  school; 16  
cases, 12 controls; middle school;26 cases,25 controls; high school; 19 cases,18  
controls; UG; 12 cases, 13 controls; PG ; 2 cases,3 controls. 
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TABLE – 4. RELIGION  DISTRIBUTION. 
RELIGION * GROUP  
   GROUP Total 
   CASE CONTROL 
RELIGION HINDU Count 59 61 120 
% within GROUP 73.8% 76.2% 75.0% 
CHRISTIA
N 
Count 14 12 26 
% within GROUP 17.5% 15.0% 16.2% 
MUSLIM Count 7 7 14 
% within GROUP 8.8% 8.8% 8.8% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
 
 
Among  the  participants  of  this  study,  Hindu  were 120 (59 cases, 61  
controls), Christians were  26 (14 cases, 12 controls),Muslims  were  14 
(7 cases, 7 controls). 
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TABLE – 5. FAMILY  DISTRIBUTION. 
FAMILY * GROUP  
   GROUP Total 
   CASE CONTROL 
FAMIL
Y 
NUCLEAR Count 63 61 124 
% within GROUP 78.8% 76.2% 77.5% 
JOINT 
FAMILY 
Count 17 19 36 
% within GROUP 21.2% 23.8% 22.5% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
 
Among  the  participants  of  this  study,  nuclear  family  were  120  (63  
cases, 61  controls),  and  the  joint  family  were 36 (17  cases,  19  controls).   
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TABLE – 6. SOCIO ECONOMIC STATUS. 
SES * GROUP  
   GROUP Total 
   CASE CONTROL 
SES LOWER  SES Count 45 42 87 
% within GROUP 56.2% 52.5% 54.4% 
MIDDLE SES Count 35 35 70 
% within GROUP 43.8% 43.8% 43.8% 
UPPER SES Count 0 3 3 
% within GROUP .0% 3.8% 1.9% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
 
Among  the  participants,  low  SES  were  87 (45 cases, 42 controls), middle   
SES  were 70 (35 cases, 35 controls),  and  the  upper  SES were 3 (0 cases,  3  
controls). 
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TABLE – 7. INCOME  DISTRIBUTION. 
INCOME * GROUP  
   GROUP Total 
   CASE CONTROL 
INCOM
E 
LESS THAN 5000 Count 45 42 87 
% within 
GROUP 
56.2% 52.5% 54.4% 
Rs 5000-10000 Count 30 33 63 
% within 
GROUP 
37.5% 41.2% 39.4% 
MORE THAN 
10000 
Count 5 5 10 
% within 
GROUP 
6.2% 6.2% 6.2% 
Total Count 80 80 160 
% within 
GROUP 
100.0% 100.0% 100.0% 
 
 
 
Income  less  than  Rs. 5000  were  87 (45 cases, 42 controls), Rs.5000 – Rs. 
10000 were  63(30 cases, 33  controls),  and  more than Rs. 10000  were  10  
(5 cases,  5 controls)  were  included  in  this  study. 
 
 
LESS 
THAN 
5000
Rs 5000-
10000
MORE 
THAN 
10000
CASE 45 56.20% 30 37.50% 5 6.20%
CONTROL 42 52.50% 33 41.20% 5 6.20%
0
10
20
30
40
50
A
xi
s T
itl
e
GRAPH -7, INCOME
81 
 
TABLE – 8. OCCUPATION  DISTRIBUTION. 
OCCUPATION * GROUP  
   GROUP Total 
   CASE CONTROL 
OCCUPATION UNEMPLOYED Count 16 12 28 
% within GROUP 20.0% 15.0% 17.5% 
UNSKILLED Count 3 2 5 
% within GROUP 3.8% 2.5% 3.1% 
SEMI-SKILLED Count 14 18 32 
% within GROUP 17.5% 22.5% 20.0% 
SKILLED Count 12 13 25 
% within GROUP 15.0% 16.2% 15.6% 
FARMER-CLERK-
SELF EMPLOYED 
Count 32 29 61 
% within GROUP 40.0% 36.2% 38.1% 
SEMI- PROFESSION Count 3 5 8 
% within GROUP 3.8% 6.2% 5.0% 
PROFESSION Count 0 1 1 
% within GROUP .0% 1.2% .6% 
Total Count 80 80 160 
% within  GROUP 100.0% 100.0% 100.0% 
 
GRAPH 8, OCCUPATION: 
 
In  this  study,  Un employed   were  28  (16  cases,  12  controls), Un skilled   
were  5 (3  cases,  2  controls),  Semi skilled  were 32 (14  cases,  18  controls), 
Skilled   were 25 (12  cases,  13  controls), Farmer / Clerk /Self  employed  were  
61 (32  cases,  29  controls),  Semi professional  were  8 (3  cases,  5  controls),   
and  Professionals  were  1 (0  case,  1  control)  were  included  in  this  study. 
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TABLE -9. RESIDENCE  DISTRIBUTION. 
RESIDENCE * GROUP  
   GROUP Total 
   CASE CONTROL 
RESIDENCE URBAN Count 54 55 109 
% within 
GROUP 
67.5% 68.8% 68.1% 
RURAL Count 26 25 51 
% within 
GROUP 
32.5% 31.2% 31.9% 
Total Count 80 80 160 
% within 
GROUP 
100.0% 100.0% 100.0% 
 
 
 
Among  the  participants  109  were  in  urban  region (54  cases,  55  
controls) and  51  were  in  rural  region (26  cases,  25  controls). 
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TABLE -10. GLYCEMIC  CONTROL  IN  CASES. 
GLY_CONTROL * GROUP  
   GROUP Total 
   CASE CONTROL 
GLY_CONTRO
L 
0 Count 0 80 80 
% within GROUP .0% 100.0% 50.0% 
1 Count 37 0 37 
% within GROUP 46.2% .0% 23.1% 
2 Count 40 0 40 
% within GROUP 50.0% .0% 25.0% 
3 Count 3 0 3 
% within GROUP 3.8% .0% 1.9% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
GRAPH – 10, Glycemic  Control  In  Cases. 
 
Among  the  type 2  diabetic  patients,  30  were  in  good  glycemic  control,  
40  were  in  fair  glycemic  control,  and  3  were  in  poor  glycemic  control. 
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TABLE – 11. MENOPAUSE  STATUS.  
MENOPAUSE STATUS * GROUP  
   GROUP Total 
   CASE CONTROL 
MENOP_STATU
S 
NO Count 74 74 148 
% within 
GROUP 
92.5% 92.5% 92.5% 
YES Count 6 6 12 
% within 
GROUP 
7.5% 7.5% 7.5% 
Total Count 80 80 160 
% within 
GROUP 
100.0% 100.0% 100.0% 
 
 
GRAPH – 11, MENOPAUSE  STATUS: 
 
 
Menopause  status  among  type 2  diabetic  patients  were  6  and  also  in  
the  control  group  were  6,  and  they  are  included  in  this  study. 
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TABLE – 12. SEXUAL  CONTACTS  IN  LAST  MONTH. 
SEXUAL_CONT_LMONTH * GROUP  
   GROUP Total 
   CASE CONTRO
L 
SEXUAL_CONT_LM
ONTH 
NO Count 20 12 32 
% within 
GROUP 
25.0% 15.0% 20.0% 
YES Count 58 64 122 
% within 
GROUP 
72.5% 80.0% 76.2% 
MISSIN
G 
Count 2 4 6 
% within 
GROUP 
2.5% 5.0% 3.8% 
Total Count 80 80 160 
% within 
GROUP 
100.0% 100.0% 100.0% 
Chi  square; 35.584a, df; 6, p – value; 0.000. SIGNIFICANT. 
 
Among  the  participants,  there  was  no  sexual  contact  in  last  month  
were  32 (20  cases, 12  controls),  sexual  contact  present  in  last  month  were  
122 (58  cases,  64  controls),  and  the  sexual  contact  was  missing  due  to  
physical  conditions,  and  due  to  religious  purpose  were  6 (2  cases,  4  
controls). 
CASE
CONTROL
0
20
40
60
80
A
xi
s T
itl
e
GRAPH -12, Sexual contact last month 
86 
 
TABLE – 13. SEXUAL  PARTNER  HOWLONG. 
SEXUAL _PART_HOWLONG * GROUP  
   GROUP Total 
   CASE CONTROL 
SEXUAL 
_PART_HOWLONG 
> 10 yrs Count 60 64 124 
% within GROUP 75.0% 80.0% 77.5% 
7-10 yrs Count 19 15 34 
% within GROUP 23.8% 18.8% 21.2% 
4-6 yrs Count 1 1 2 
% within GROUP 1.2% 1.2% 1.2% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
 
Among  the  participants  of  this  study,  sexual  relationship  with  partner  
for  more  than 10  years  were  124 (60  cases,  64  controls),  between  7 – 10  
years  were  34 (19  cases,  15  controls),  and  between  4 – 6  years  were  2(1 
case,  1 control). 
 
 
 
 
> 10 yrs
7-10 yrs
4-6 yrs
60
19
1
64
15
1
GRAPH -13, Sexual Partner  Howlong
CASE CONTROL
87 
 
TABLE -14. ROLE  OF  SEXUALITY. 
ROLE_SEXUALITY * GROUP   GROUP Total 
 CASE CONTR
OL 
ROLE_SEXUA
LITY 
LESS 
IMPORTANT 
Count 37 43 80 
% within 
GROUP 
46.2% 53.8% 50.0% 
MORE 
IMPORTANT 
Count 43 37 80 
% within 
GROUP 
53.8% 46.2% 50.0% 
Total Count 80 80 160 
% within 
GROUP 
100.0% 100.0% 100.0% 
    
GRAPH – 14 (i), ROLE  OF  SEXUALITY  IN  CASES.                                                                                                                                                        
   
 
  GRAPH – 14 (ii), ROLE  OF  SEXUALITY  IN  CONTROLS.                                                                                                                                                                                                                                                        
 
 Role  of  sexuality   was  less  important  were  80 (37  cases,  43  control),  
more  important  were  80 (43  cases, 37  controls)  reported. 
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TABLE – 15. SEXUAL  ACTIVITY  DISTRIBUTION. 
 
SEXUAL_ACTIVITY * GROUP  
   GROUP Total 
   CASE CONTROL 
SEXUAL_ACTIVIT
Y 
NO, LITTLE Count 17 34 51 
% within GROUP 21.2% 42.5% 31.9% 
MILD Count 13 19 32 
% within GROUP 16.2% 23.8% 20.0% 
MODERATE Count 9 11 20 
% within GROUP 11.2% 13.8% 12.5% 
SEVERE Count 41 16 57 
% within GROUP 51.2% 20.0% 35.6% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
 
Regarding  the  sexual  activity  among  the  participants,  no  problem  in  
sexual  activity  reported  was  51 (17  cases,  34  controls),  mild  problem  was  32 
(13  cases,  19  controls),  moderate  problem  was  20 (9  cases,  11  controls,  and  
the  severe  problem  was  57 (41  cases,  16  controls)  reported. 
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TABLE – 16. SEXUAL  DYSFUNCTION – SELF  VIEW. 
SEXUAL _DYSFUN_SELFVIEW * GROUP  
   GROUP Total 
   CASE CONTROL 
SEXUAL 
_DYSFUN_SELFVIEW 
NO, LITTLE Count 22 42 64 
% within GROUP 27.5% 52.5% 40.0% 
MILD Count 20 17 37 
% within GROUP 25.0% 21.2% 23.1% 
MODERAT
E 
Count 21 16 37 
% within GROUP 26.2% 20.0% 23.1% 
SEVERE Count 17 5 22 
% within GROUP 21.2% 6.2% 13.8% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
GRAPH – 16, SEXUAL  DYSFUNCTION  SELF  VIEW: 
 
Regarding  the  sexual  (dys)  function  self  view  report,  no  problem  
reported  was  64 (22  cases,  42  controls),  mild  problem  was  37 (20  cases,  17  
controls),  moderate  problem  was  37 (21  cases,  16  controls),  and  the  severe  
problem  reported  was  22 (17 cases,  5  controls). 
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TABLE – 17. SEXUAL  DYSFUCTION  PRTNER  VIEW. 
SEXUAL _DYSFUN_PARTVIEW * GROUP  
   GROUP Total 
   CASE CONTROL 
SEXUAL 
_DYSFUN_PARTVIEW 
NO, LITTLE Count 19 44 63 
% within GROUP 23.8% 55.0% 39.4% 
MILD Count 13 9 22 
% within GROUP 16.2% 11.2% 13.8% 
MODERAT
E 
Count 19 12 31 
% within GROUP 23.8% 15.0% 19.4% 
SEVERE Count 29 15 44 
% within GROUP 36.2% 18.8% 27.5% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
 
GRAPH – 17, SEUAL  DYSFUNCTION  PARTNER’S  VIEW: 
 
Regarding  the  sexual  (dys) function  partner  view,  no  problem  was  
reported  in  63  participants (19  cases,  44  controls),  mild  problem  was  22 (13  
cases,  9  controls), moderate  problem  was  31  (19  cases,  12  controls),  and  
severe  problem  was  reported  in  44 (29  cases,  15  controls). 
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TABLE – 18, BDI  DISTRIBUTION. 
 
                   BDI 
  Patients   Total 
 Type 2 DM  Normal 
 BDI_ 
   Normal 
   N0   38   66   104 
   %   47.5%   82.5%   65.0% 
   Mild 
   N0   30   9   39 
   %   37.5%   11.2%   24.4% 
  Border line depression 
  N0   6   3   9 
  %   7.5%   3.8%   5.6% 
  Moderate 
  N0   6   2   8 
  %   7.5%   2.5%   5.0% 
Total 
  N0   80   80   160 
 %   100.0%  100.0% 100.0% 
p – value;0.000, Odds  ratio; 5.21, 95%  confident  interval (.093, .396) Pearson  
Chi  squre;21.846,  df;3,   
Among  80   type 2  diabetic  patients  42  patients  had  the  symptoms  of  
depression (52.5%),  and  among  the  control  group  14  individuals (17.5%)  had  
symptoms  of  depression  in  varying  severity. Among  42  type 2  diabetic  
patients  with  depression,  30  patients  (37.5%)  had  mild  depression,6  patients 
(7.5%)  had  borderline  depression,  and  6 patients (7.5%)  had  moderate  
depression,  and  among 14  non – diabetic  individuals, 9  individuals(11.2%)  had  
mild  depression,  3  individuals (3.8%)  had  borderline  depression  and  2  
individuals (2.5%)  had  moderate  depression.p – value; 0.000, (Statistically 
significant),  Odds Ratio for Group (case / control)  = 5.21,  95% Confidence 
Interval (.093, .396) Pearson  Chi  squre;21.846,  df;3,  which  implies  that  
depression  symptoms  among  T2DM  patients  are  5.2  times   higher  than  the  
non – diabetic  general  population. 
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GRAPH – 18, BDI  DISTRIBUTION. 
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TABLE – 19. HAM – A  DISTRIBUTION. 
 
 
        HAM - A 
  Patients Total 
  type 2 DM   Normal 
 HAM - A 
   Not Present 
   N0    39    65    104 
   %    48.8%    81.2%    65.0% 
   Mild 
   N0    31    11    42 
   %    38.8%    13.8%    26.2% 
   Mild to moderate 
   N0    6    3    9 
   %    7.5%    3.8%    5.6% 
   Moderate to severe 
   N0    4    1    5 
   %    5.0%    1.2%    3.1% 
   Total 
   N0    80    80    160 
   %    100.0%    100.0%    100.0% 
 
Among  80   type 2 diabetic  patients  41  patients  had  the  symptoms  of  
anxiety (51.25%),  and  among  the  control  group  15 individuals (18.8%)  had  
symptoms  of  depression  in  varying  severity. Among  41  type 2  diabetic  
patients  with  anxiety,  31  patients (38.8%)  had  mild  anxiety,6  patients (7.5%)  
had  mild  to  moderate  anxiety,  and  4 patients (5.0%)  had  moderate  anxiety,  
and   among 15  non – diabetic  individuals, 11  individuals(13.8%)  had  mild  
anxiety,  3  individuals (3.8%)  had  mild  to  moderate  anxiety, and  1  
individuals(1.2%)  had  moderate  anxiety.  (Chi – squre;13.434, p – value;<0.001). 
Odds  ratio; 4.12;  implies  that   anxiety  symptoms  among  type 2  diabetic  
patients  are  4.12  times  more  than  non – diabetic  individuals. 
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GRAPH – 19, HAM – A  DISTRIBUTION. 
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TABLE – 20. QSF – TOTAL. 
 
                      QSF - TOTAL 
  Patients    Total 
   type 2 DM    Normal 
  QSF - TOTAL 
   No 
   N0    35    60    95 
   %    43.8%    75.0%    59.4% 
   Mild 
   N0    22    8    30 
   %    27.5%    10.0%    18.8% 
   Moderate 
   N0    16    10    26 
   %    20.0%    12.5%    16.2% 
   Severe 
   N0    7    2    9 
   %    8.8%    2.5%    5.6% 
    Total 
   N0    80    80    160 
   %    100.0%    100.0%    100.0% 
 
Quality  of  Sexual  Function,  56.2%  (n=45)  of  the T2DM  patients  had  
 sexual  dysfunction  in  varying  degrees.  
Among  45  patients  of T2DM,  22  patients  had  mild  degree  of  sexual  
dysfunction (27.5%),  16  patients  had  moderate  degree  of  sexual  dysfunction  
(20%),  and  7  patients  had  severe  degree (8.8%).  In  the  control  group,  only  
25%  (n= 20) of the  individuals  had  varying  degrees  of  sexual  dysfunction,  
among  them  mild; 8 (10%),  moderate; 10 (12.5%),  and  severe;  2 (2.5%). Odds  
ratio; 3.85,  p- value 0.001  implies  statistically  significant; i.e. in  T2DM  
patients  sexual  dysfunction  is  3.85  times  higher than  non – diabetic  general  
population.  
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GRAPH – 20, QSF – TOTAL  DISTRIBUTION. 
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TABLE – 21. PSYCHO SOMATIC QoL.  
PSYCHO  SOMATIC  QoL. 
   GROUP Total 
   CASE CONTROL 
PSYCHO _SOMATIC_ 
QOL 
NO, LITTLE Count 20 43 63 
% within GROUP 25.0% 53.8% 39.4% 
MILD Count 25 18 43 
% within GROUP 31.2% 22.5% 26.9% 
MODERATE Count 19 12 31 
% within GROUP 23.8% 15.0% 19.4% 
SEVERE Count 16 7 23 
% within GROUP 20.0% 8.8% 14.4% 
Total Count 80 80 160 
% within GROUP 100.0% 100.0% 100.0% 
Pearson Chi-Square  P- VALUE -0.002 SIGNIFICANT 
GRAPH – 21, PSYCHO  SOMATIC  QoL 
 
 
In  this,  75%  (n=60) of  the  T2DM  patients  had  complaints  in  this  
domain, where  as  in  control  group  only  46.2% (n=37) . Among  60  T2DM  
patients,  mild; 25 (31.2%),  moderate; 19 (23.8%),  severe; 16 (20%),  and  in  the  
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control  group  mild; 18 (22.5%),  moderate; 12  (15%),  and  the  severe; 7 (8.8%)  
were  reported. p – value; 0.002. Significant. Odds  ratio; 3.486;  implies  that  
Psycho – somatic  quality  of  life  among  T2DM  patients  is  3.5  times  affected  
more,  than  with  non – diabetic  individual 
ADDITIONAL  TABLE; 
ASSOCIATION  OF  PRESENCE  DEPRESSION  AND  ANXIETY  IN BOTH  CASE AND CONTROLS 
 VAR00001 Percentage 
Both  BDI & 
HAMA 
Group 1; T2DM/Group 2;normal type 2 dm Count 23 79% 
% of  DM  46  
Normal Count 6 21% 
% of al 12%  
Total Count 29  
% of Total 100.0% 100% 
29 Participants  had  both  anxiety  and  depression. 
BDI_ * HAMA Crosstabulation 
 HAMA Total 
Mild Mild to 
moderate 
Moderate to 
severe 
BDI_ Mild Count 14 4 0 18 
% within BDI_ 77.8% 22.2% .0% 100.0% 
Border line depression Count 3 2 1 6 
% within BDI_ 50.0% 33.3% 16.7% 100.0% 
Moderate Count 2 2 1 5 
% within BDI_ 40.0% 40.0% 20.0% 100.0% 
Total Count 19 8 2 29 
% within BDI_ 65.5% 27.6% 6.9% 100.0% 
T2DM;  23,  Non  Diabetic; 6. Odds  ratio; 4.97. 
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TABLE:22 . ASSOCIATION FOR DEMOGRAPHIC VARIABLE AND DEPRESSION FOR DM 
  BDI_ 
  Normal Mild Border line 
d i  
Moderate severe Extreme 
  No % No % No % No % No % No % Chi 
square P value 
SEX 
Male 27 71.10% 20 66.70% 4 66.70% 3 50.00% 0 0.00% 0 0.00% 
1.068 0.785 
Female 11 28.90% 10 33.30% 2 33.30% 3 50.00% 0 0.00% 0 0.00% 
EDUCATION 
Illiterate 2 5.30% 2 6.70% 0 0.00% 1 16.70% 0 0.00% 0 0.00% 
20.06 0.169 
Primary 
S h l 
5 13.20% 10 33.30% 0 0.00% 1 16.70% 0 0.00% 0 0.00% 
Middle 
h l 
16 42.10% 5 16.70% 2 33.30% 3 50.00% 0 0.00% 0 0.00% 
High school 7 18.40% 8 26.70% 4 66.70% 0 0.00% 0 0.00% 0 0.00% 
UG 6 15.80% 5 16.70% 0 0.00% 1 16.70% 0 0.00% 0 0.00% 
PG 2 5.30% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
Professional 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
FAMILY 
Nuclear 30 78.90% 26 86.70% 2 33.30% 5 83.30% 0 0.00% 0 0.00% 
8.595 0.035* 
Joint Family 8 21.10% 4 13.30% 4 66.70% 1 16.70% 0 0.00% 0 0.00% 
SES 
Low 20 52.60% 16 53.30% 4 66.70% 5 83.30% 0 0.00% 0 0.00% 
2.359 0.501 
Middle 18 47.40% 14 46.70% 2 33.30% 1 16.70% 0 0.00% 0 0.00% 
Upper 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
INCOME 
< Rs 5000 20 52.60% 16 53.30% 4 66.70% 5 83.30% 0 0.00% 0 0.00% 
5.59 
  
0.536 
  
Rs5000- Rs 
10000 
16 42.10% 12 40.00% 2 33.30% 0 0.00% 0 0.00% 0 0.00% 
More than 
 10000 
2 5.30% 2 6.70% 0 0.00% 1 16.70% 0 0.00% 0 0.00% 
  Professional 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
RESIDENCE 
Urban 27 71.10% 19 63.30% 4 66.70% 4 66.70% 0 0.00% 0 0.00% 
0.46 0.928 
Rural 11 28.90% 11 36.70% 2 33.30% 2 33.30% 0 0.00% 0 0.00% 
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TABLE: 23. ASSOCIATION FOR DEMOGRAPHIC VARIABLE AND DEPRESSION FOR NORMAL 
  BDI_     
Normal Mild Border line 
d i  
Moderate severe Extreme     
N0 Column 
N % 
N0 Column 
N % 
N0 Column 
N % 
N0 Column 
N % 
N0 Column 
N % 
N0 Column 
N % 
    
SEX 
Male 48 72.70% 5 55.60% 0 0.00% 1 50.00% 0 0.00% 0 0.00% 
7.917* 0.047 Female 18 27.30% 4 44.40% 3 100.00% 1 50.00% 0 0.00% 0 0.00% 
EDUCATION 
Illiterate 6 9.10% 0 0.00% 2 66.70% 1 50.00% 0 0.00% 0 0.00% 
3.631* 0.007 
Primary 
S h l 
8 12.10% 4 44.40% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
Middle 
h l 
22 33.30% 3 33.30% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
High school 17 25.80% 1 11.10% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
UG 11 16.70% 1 11.10% 0 0.00% 1 50.00% 0 0.00% 0 0.00% 
PG 2 3.00% 0 0.00% 1 33.30% 0 0.00% 0 0.00% 0 0.00% 
Professional 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
FAMILY 
Nuclear 52 78.80% 6 66.70% 2 66.70% 1 50.00% 0 0.00% 0 0.00% 
1.604 0.658 Joint 
F il  
14 21.20% 3 33.30% 1 33.30% 1 50.00% 0 0.00% 0 0.00% 
SES 
Low 35 53.00% 4 44.40% 2 66.70% 1 50.00% 0 0.00% 0 0.00% 
9.354 0.155 
Middle 29 43.90% 5 55.60% 0 0.00% 1 50.00% 0 0.00% 0 0.00% 
Upper 2 3.00% 0 0.00% 1 33.30% 0 0.00% 0 0.00% 0 0.00% 
INCOME 
< Rs 5000 35 53.00% 4 44.40% 2 66.70% 1 50.00% 0 0.00% 0 0.00% 
13.278* 0.038 
Rs5000- Rs 
10000 
28 42.40% 5 55.60% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
More than 
R  10000 
3 4.50% 0 0.00% 1 33.30% 1 50.00% 0 0.00% 0 0.00% 
RESIDENCE 
Urban 46 69.70% 7 77.80% 1 33.30% 1 50.00% 0 0.00% 0 0.00% 
2.448 0.485 Rural 20 30.30% 2 22.20% 2 66.70% 1 50.00% 0 0.00% 0 0.00% 
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TABLE:24 .ASSOCIATION FOR DEMOGRAPHIC VARIABLE ABD  ANXIETY FOR DM 
  HAMA     
Not Present Mild Mild to moderate Moderate to 
 
Severe     
No % No % No % No % No %     
SEX 
Male 34 87.20% 11 35.50% 5 83.30% 4 100.00% 0 0.00% 
23.981* p<0.001 Female 5 12.80% 20 64.50% 1 16.70% 0 0.00% 0 0.00% 
EDUCATION 
Illiterate 3 7.70% 1 3.20% 0 0.00% 1 25.00% 0 0.00% 
45.106* p<0.001 
Primary 
School 8 20.50% 6 19.40% 2 33.30% 0 0.00% 0 0.00% 
Middle 
school 12 30.80% 12 38.70% 2 33.30% 0 0.00% 0 0.00% 
High school 10 25.60% 7 22.60% 1 16.70% 1 25.00% 0 0.00% 
UG 6 15.40% 5 16.10% 1 16.70% 0 0.00% 0 0.00% 
PG 0 0.00% 0 0.00% 0 0.00% 2 50.00% 0 0.00% 
Professional 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
FAMILY 
Nuclear 32 82.10% 24 77.40% 4 66.70% 3 75.00% 0 0.00% 
0.844 0.839 Joint 
 
7 17.90% 7 22.60% 2 33.30% 1 25.00% 0 0.00% 
SES 
Low 22 56.40% 17 54.80% 4 66.70% 2 50.00% 0 0.00% 
0.354 0.95 
Middle 17 43.60% 14 45.20% 2 33.30% 2 50.00% 0 0.00% 
Upper 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
INCOME 
< Rs 5000 22 56.40% 17 54.80% 4 66.70% 2 50.00% 0 0.00% 
7.747 0.257 
Rs5000- Rs 
10000 
17 43.60% 11 35.50% 1 16.70% 1 25.00% 0 0.00% 
More than 
Rs 10000 0 0.00% 3 9.70% 1 16.70% 1 25.00% 0 0.00% 
RESIDENCE 
Urban 27 69.20% 22 71.00% 4 66.70% 1 25.00% 0 0.00% 
3.519 0.318 Rural 12 30.80% 9 29.00% 2 33.30% 3 75.00% 0 0.00% 
*. The Chi-square statistic is significant at the .05 
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TABLE:25 .ASSOCIATION FOR DEMOGRAPHIC VARIABLE ABD ANXIETY  FOR NORMAL 
 
  HAMA     
Not Present Mild Mild to moderate Moderate to 
 
Severe     
N0 Column 
  
N0 Column 
  
N0 Column 
  
N0 Column 
  
N0 Column 
  
    
SEX 
Male 49 75.40% 4 36.40% 0 0.00% 1 100.00% 0 0.00% 
13.416* 0.004 
Female 16 24.60% 7 63.60% 3 100.00% 0 0.00% 0 0.00% 
EDUCATION 
Illiterate 4 6.20% 3 27.30% 2 66.70% 0 0.00% 0 0.00% 
26.79* 0.03 
Primary 
 
11 16.90% 0 0.00% 1 33.30% 0 0.00% 0 0.00% 
Middle 
 
19 29.20% 6 54.50% 0 0.00% 0 0.00% 0 0.00% 
High school 16 24.60% 2 18.20% 0 0.00% 0 0.00% 0 0.00% 
UG 12 18.50% 0 0.00% 0 0.00% 1 100.00% 0 0.00% 
PG 3 4.60% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
Professional 0 0.00% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
FAMILY 
Nuclear 51 78.50% 8 72.70% 1 33.30% 1 100.00% 0 0.00% 
3.614 0.306 
Joint 
 
14 21.50% 3 27.30% 2 66.70% 0 0.00% 0 0.00% 
SES 
Low 30 46.20% 10 90.90% 2 66.70% 0 0.00% 0 0.00% 
9.186 0.163 
Middle 32 49.20% 1 9.10% 1 33.30% 1 100.00% 0 0.00% 
Upper 3 4.60% 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
INCOME 
< Rs 5000 30 46.20% 10 90.90% 2 66.70% 0 0.00% 0 0.00% 
23.038* 0.001 
Rs5000- Rs 
 
31 47.70% 1 9.10% 1 33.30% 0 0.00% 0 0.00% 
More than 
  
4 6.20% 0 0.00% 0 0.00% 1 100.00% 0 0.00% 
RESIDENCE 
Urban 49 75.40% 4 36.40% 1 33.30% 1 100.00% 0 0.00% 
8.908* 0.031 
Rural 16 24.60% 7 63.60% 2 66.70% 0 0.00% 0 0.00% 
*significant at p <0.05 
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TABLE:26.(i) 1ASSOCIATION FOR DEMOGRAPHIC VARIABLE  - QSF FOR DM 
 
  QSFTOTAL     
No Mild Moderate Severe     
No % No % No % No % chi  square p value 
SEX Male 26 74.30% 15 68.20% 9 56.20% 4 57.10% 2.005 0.571 
Female 9 25.70% 7 31.80% 7 43.80% 3 42.90% 
EDUCATION 
Illiterate 2 5.70% 2 9.10% 0 0.00% 1 14.30% 
17.707 0.278 
Primary School 4 11.40% 7 31.80% 4 25.00% 1 14.30% 
Middle school 8 22.90% 6 27.30% 9 56.20% 3 42.90% 
High school 12 34.30% 4 18.20% 1 6.20% 2 28.60% 
UG 7 20.00% 3 13.60% 2 12.50% 0 0.00% 
PG 2 5.70% 0 0.00% 0 0.00% 0 0.00% 
Professional 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
FAMILY Nuclear 32 91.40% 14 63.60% 11 68.80% 6 85.70% 7.524 0.057 
Joint Family 3 8.60% 8 36.40% 5 31.20% 1 14.30% 
SES 
Low 16 45.70% 14 63.60% 10 62.50% 5 71.40% 
2.976 0.395 Middle 19 54.30% 8 36.40% 6 37.50% 2 28.60% 
Upper 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
INCOME 
< Rs 5000 16 45.70% 14 63.60% 10 62.50% 5 71.40% 
4.113 0.661 Rs5000- Rs 10000 17 48.60% 6 27.30% 5 31.20% 2 28.60% 
More than Rs 
 
2 5.70% 2 9.10% 1 6.20% 0 0.00% 
RESIDENCE Urban 24 68.60% 15 68.20% 11 68.80% 4 57.10% 0.377 0.946 
Rural 11 31.40% 7 31.80% 5 31.20% 3 42.90% 
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TABLE: 26.(ii)ASSOCIATION FOR DEMOGRAPHIC VARIABLE AND QSF FOR NORMAL PATIENTS 
  QSFTOTAL     
No Mild Moderate Severe     
No % No % No % No % chi square p value 
SEX 
Male 46 76.70
 
5 62.50% 3 30.00% 0 0.00% 
12.953* 0.005 
Female 14 23.30
 
3 37.50% 7 70.00% 2 100.00% 
EDUCATION 
Illiterate 3 5.00% 1 12.50% 4 40.00% 1 50.00% 
21.161 0.118 
Primary 
 
9 15.00
 
2 25.00% 0 0.00% 1 50.00% 
Middle school 20 33.30
 
3 37.50% 2 20.00% 0 0.00% 
High school 15 25.00
 
2 25.00% 1 10.00% 0 0.00% 
UG 11 18.30
 
0 0.00% 2 20.00% 0 0.00% 
PG 2 3.30% 0 0.00% 1 10.00% 0 0.00% 
Professional 0 0.00% 0 0.00% 0 0.00% 0 0.00% 
FAMILY 
Nuclear 46 76.70
 
7 87.50% 6 60.00% 2 100.00% 
2.646 0.449 
Joint Family 14 23.30
 
1 12.50% 4 40.00% 0 0.00% 
SES 
Low 31 51.70
 
4 50.00% 6 60.00% 1 50.00% 
2.114 0.909 
Middle 27 45.00
 
4 50.00% 3 30.00% 1 50.00% 
Upper 2 3.30% 0 0.00% 1 10.00% 0 0.00% 
INCOME 
< Rs 5000 31 51.70
 
4 50.00% 6 60.00% 1 50.00% 
1.489 0.96 
Rs5000- Rs 
 
25 41.70
 
4 50.00% 3 30.00% 1 50.00% 
More than Rs 
 
4 6.70% 0 0.00% 1 10.00% 0 0.00% 
RESIDENCE 
Urban 43 71.70
 
5 62.50% 6 60.00% 1 50.00% 
1.067 0.785 
Rural 17 28.30
 
3 37.50% 4 40.00% 1 50.00% 
*significant at p <0.05 
The  above  tables  explained  the  various  demographic  variables  of  both  in  case   and  control  groups  in  association  
with  depression,  anxiety  and  the  QSF  total  and  significance  with  chi – Square  value,  significant  p – value . 
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TABLE – 27. ASSOCIATION  OF  DURATION  AND  AGE  OF  ONSET 
 
ASSOCIATION  OF  DURATION  OF  T2DM  AND  AGE  OF  ONSET   
 age onset Total Chi 
square 
P value 
<30 Yrs 30-40 Yrs Above 40Yrs 
Duration 
< 5 yrs 
N0 4 10 5 19 13.207a .P<0.05 
%  25.0% 17.2% 83.3% 23.8% 
5-10 Yrs 
N0 11 43 1 55 
%  68.8% 74.1% 16.7% 68.8% 
Above 10 Yrs 
N0 1 5 0 6 
%  6.2% 8.6% 0.0% 7.5% 
Total 
N0 16 58 6 80 
%  100.0% 100.0% 100.0% 100.0% 
GRAPH – 22, DURATION  OT T2DM  AND  AGE  OF  ONEST 
 
Most of  the  cases,  reported  in  30 – 40  years. 
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TABLE -28.  
ASSOCIATION  OF   GLYCEMIC  CONTROL  WITH  AGE  OF  ONSET   
 age onset Total   
<30 Yrs 30-40 Yrs Above 40Yrs Chi 
square 
P value 
glycemic control 
Good 
N0 11 23 3 37   
% 68.8% 39.7% 50.0% 46.2% 20.873a P<0.001 
Fair 
N0 5 34 1 40   
% 31.2% 58.6% 16.7% 50.0%   
Poor 
N0 0 1 2 3   
% 0.0% 1.7% 33.3% 3.8%   
Total 
N0 16 58 6 80   
% 100.0% 100.0% 100.0% 100.0%   
 
GRAPH – 23, GLYCEMIC  CONTROL  AND  AGE OF  ONSET. 
 
Most  of  the  cases  had  a  fair  glycemic  control,  earlier  onset  had  fair  
glycemic  control. 
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TABLE -29 (i). 
ROLE  OF  SEXUALITY  WITH  QSF  TOTAL  IN  T2DM   
 QSFTOTAL Total   
No Mild Moder
ate 
Severe Chi-
Square 
P Value 
ROLE_OF_SEX
UALITY 
Less 
important 
N0 7 15 10 5 37   
% 20.0% 68.2% 62.5% 71.4% 46.2%   
More 
important 
N0 28 7 6 2 43   
% 80.0% 31.8% 37.5% 28.6% 53.8% 17.443a .001 
Total N0 35 22 16 7 80   
% 100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
  
 
TABLE – 29 (ii). 
ROLE  OF  SEXUALITY  WITH  QSF  TOTAL  IN  CONTROLS   
 QSFTOTAL Total   
No Mild Moder
ate 
Severe Chi-
Square 
P Value 
ROLE_OF_SEX
UALITY 
Less 
important 
N0 27 6 9 1 43   
% 45.0% 75.0% 90.0% 50.0% 53.8%   
More 
important 
N0 33 2 1 1 37 8.598a P<0.05 
% 55.0% 25.0% 10.0% 50.0% 46.2%   
Total N0 60 8 10 2 80   
% 100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
  
Role  of  sexuality  had  an  impact  on  quality  of  sexual  function  in  both  
cases (Chi square; 17.433, p – value ; 0.001) and  in  control (Chi;8.598, p; <0.05). 
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TABLE – 30 (i). 
MENOPAUSE  STATUS  WITH  QSF  TOTAL  IN  T2DM   
 QSFTOTAL Total   
No Mild Modera
te 
Severe Chi-
Square 
P Value 
MENOPAUSE_ST
ATUS 
No Count 35 20 12 7 74   
% within 
QSFTOTAL 
100.0% 90.9% 75.0% 100.0% 92.5%   
Yes Count 0 2 4 0 6 10.549 P<0.001 
% within 
QSFTOTAL 
0.0% 9.1% 25.0% 0.0% 7.5%   
Total Count 35 22 16 7 80   
% within 
QSFTOTAL 
100.0% 100.0% 100.0% 100.0% 100.0%   
 
TABLE – 30 (ii). 
MENOPAUSE  STATUS  WITH  QSF  TOTAL  IN  CONTROL   
 QSFTOTAL Total   
No Mild Modera
te 
Severe Chi-
Square 
P Value 
MENOPAUSE_ST
ATUS 
No Count 59 7 6 2 74   
% within 
QSFTOTAL 
98.3% 87.5% 60.0% 100.0% 92.5% 18.619 P<0.001 
 
Yes Count 1 1 4 0 6   
% within 
QSFTOTAL 
1.7% 12.5% 40.0% 0.0% 7.5%   
Total Count 60 8 10 2 80   
% within 
QSFTOTAL 
100.0% 100.0% 100.0% 100.0% 100.0%   
 
TABLE – 31 (i). 
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PSYCHO  SOMATIC QoL  WITH  QSF  TOTAL  IN  T2DM   
 QSFTOTAL Total   
No Mild Moderat
e 
Severe Chi-
Square 
P Value 
PSYCHO_SOMATIC_Q
OL 
No N0 14 4 2 0 20   
% 40.0% 18.2% 12.5% 0.0% 25.0%   
Mild N0 16 5 3 1 25   
% 45.7% 22.7% 18.8% 14.3% 31.2%   
Moderat
e 
N0 5 10 4 0 19   
% 14.3% 45.5% 25.0% 0.0% 23.8%   
Severe N0 0 3 7 6 16   
% 0.0% 13.6% 43.8% 85.7% 20.0%   
Total N0 35 22 16 7 80 45.037a P<0.001 
% 100.0% 100.0% 100.0% 100.0% 100.0%   
TABLE – 31 (ii). 
PSYCHO SOMATIC QoL WITH QSF TOTAL IN CONTROL   
 QSFTOTAL Total   
No Mild Moderat
e 
Severe Chi-
Square 
P Value 
PSYCHO_SOMATIC_Q
OL 
No N0 42 0 1 0 43   
% 70.0% 0.0% 10.0% 0.0% 53.8%   
Mild N0 12 5 0 1 18   
% 20.0% 62.5% 0.0% 50.0% 22.5%   
Moderat
e 
N0 5 2 4 1 12   
% 8.3% 25.0% 40.0% 50.0% 15.0% 51.963a P<0.001 
Severe N0 1 1 5 0 7   
% 1.7% 12.5% 50.0% 0.0% 8.8%   
Total N0 60 8 10 2 80   
% 100.0% 100.0% 100.0% 100.0% 100.0%   
Association  of  psycho  somatic  quality  of  life  and  QSF  shows  that,  both  
in T2DM  patients  and  in  control  group  had  significant  p – values; < 0.00 
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TABLE – 32, PERCENTAGE  
COMPARISION . 
group_1_type_2_dm_2_no_dm 
type 2 dm Normal 
Count Column N 
% 
Count Column N 
% 
age_group 31 -35 Yrs 16 20.00% 16 20.00% 
36-40 Yrs 19 23.75% 19 23.75% 
41-45 Yrs 22 27.50% 22 27.50% 
45-50 Yrs 23 28.75% 23 28.75% 
SEX Male 54 67.50% 54 67.50% 
Female 26 32.50% 26 32.50% 
EDUCATION Illiterate 5 6.25% 9 11.25% 
Primary School 16 20.00% 12 15.00% 
Middle school 26 32.50% 25 31.25% 
High school 19 23.75% 18 22.50% 
UG 12 15.00% 13 16.25% 
PG 2 2.50% 3 3.75% 
Professional 0 0.00% 0 0.00% 
RELIGION Hindu 59 73.75% 61 76.25% 
Christian 14 17.50% 12 15.00% 
Muslim 7 8.75% 7 8.75% 
Others 0 0.00% 0 0.00% 
FAMILY Nuclear 63 78.75% 61 76.25% 
Joint Family 17 21.25% 19 23.75% 
SES Low 45 56.25% 42 52.50% 
Middle 35 43.75% 35 43.75% 
Upper 0 0.00% 3 3.75% 
INCOME < Rs 5000 45 56.25% 42 52.50% 
Rs5000- Rs 10000 30 37.50% 33 41.25% 
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More than Rs 10000 5 6.25% 5 6.25% 
MARITAL_STATUS Married 80 100.00% 80 100.00% 
Unmarried 0 0.00% 0 0.00% 
separated 0 0.00% 0 0.00% 
Widow/divorced 0 0.00% 0 0.00% 
OCCUPATION Unemployed 16 20.00% 12 15.00% 
Unskilled 3 3.75% 2 2.50% 
Semi skilled 14 17.50% 18 22.50% 
Skilled 12 15.00% 13 16.25% 
Farmer 32 40.00% 29 36.25% 
Semi professional 3 3.75% 5 6.25% 
Professional 0 0.00% 1 1.25% 
RESIDENCE Urban 54 67.50% 55 68.75% 
Rural 26 32.50% 25 31.25% 
glycemic control .00 0 0.00% 80 100.00% 
Good 37 46.25% 0 0.00% 
Fair 40 50.00% 0 0.00% 
Poor 3 3.75% 0 0.00% 
BDI_ Normal 38 47.50% 66 82.50% 
Mild 30 37.50% 9 11.25% 
Border line 
depression 
6 7.50% 3 3.75% 
Moderate 6 7.50% 2 2.50% 
severe 0 0.00% 0 0.00% 
Extreme 0 0.00% 0 0.00% 
HAMA Not Present 39 48.75% 65 81.25% 
Mild 31 38.75% 11 13.75% 
Mild to moderate 6 7.50% 3 3.75% 
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Moderate to severe 4 5.00% 1 1.25% 
Severe 0 0.00% 0 0.00% 
MENOPAUSE_STAT
US 
No 74 92.50% 74 92.50% 
Yes 6 7.50% 6 7.50% 
SEXUAL_PARTNER No 0 0.00% 0 0.00% 
Yes 80 100.00% 80 100.00% 
SEXUAL_CONTACT
SLAST_MONTH 
No 20 25.00% 12 15.00% 
Yes 58 72.50% 64 80.00% 
Missing 2 2.50% 4 5.00% 
SEXUAL_PARTNER
HOWLONG 
>10 Years 60 75.00% 64 80.00% 
7-10 Yrs 19 23.75% 15 18.75% 
4-6 Yrs 1 1.25% 1 1.25% 
1- 3 Yrs 0 0.00% 0 0.00% 
6-12 months 0 0.00% 0 0.00% 
<6 months 0 0.00% 0 0.00% 
no sex 0 0.00% 0 0.00% 
ROLE_OF_SEXUALI
TY 
Less important 37 46.25% 43 53.75% 
More important 43 53.75% 37 46.25% 
Very Important 0 0.00% 0 0.00% 
PSYCHO_SOMATIC
_QOL 
No 20 25.00% 43 53.75% 
Mild 25 31.25% 18 22.50% 
Moderate 19 23.75% 12 15.00% 
Severe 16 20.00% 7 8.75% 
SEXUAL_ACTIVITY No 17 21.25% 34 42.50% 
Mild 13 16.25% 19 23.75% 
Moderate 9 11.25% 11 13.75% 
Severe 41 51.25% 16 20.00% 
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SEXUAL_DYSFUNC
TIONSELF_VIEW 
No 22 27.50% 42 52.50% 
Mild 20 25.00% 17 21.25% 
Moderate 21 26.25% 16 20.00% 
Severe 17 21.25% 5 6.25% 
SEXUAL_DYSFUNC
TIONPARTNER_VIE
W 
No 19 23.75% 44 55.00% 
Mild 13 16.25% 9 11.25% 
Moderate 19 23.75% 12 15.00% 
Severe 29 36.25% 15 18.75% 
QSFTOTAL No 35 43.75% 60 75.00% 
Mild 22 27.50% 8 10.00% 
Moderate 16 20.00% 10 12.50% 
Severe 7 8.75% 2 2.50% 
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DISCUSSION: 
 
In  this  study,  our  1st  hypothesis  was   the  prevalence  of  depression  is  
more  among  type 2  diabetic  patients  than age  matched   non – diabetic  
individuals. 
This  study  showed  that  the  prevalence  of  depression  among  T2DM  
patients  is  three  times  than  the  non – diabetic general  population.  Among  80   
type 2 diabetic  patients  42  patients  had  the  symptoms  of  depression (52.5%),  
and  among  the  control  group  14  individuals (17.5%)  had  symptoms  of  
depression  in  varying  severity.  
 
Among  42  type 2  diabetic  patients  with  depression,  30  patients (37.5%)  
had  mild  depression,6  patients (7.5%)  had  borderline  depression,  and  6 
patients (7.5%)  had  moderate  depression,  and  among 14  non – diabetic  
individuals, 9  individuals(11.2%)  had  mild  depression,  3  individuals (3.8%)  
had  borderline  depression  and  2  individuals (2.5%)  had  moderate  depression. 
These  results  shows  that  more  than  three  times  increased  prevalence  of  
depression  present  among  T2DM  patients  than  non – diabetic  general  
population  with  a  p – value; 0.000, (Statistically significant),  Odds Ratio for 
Group (case / control) = 5.21,  95% Confidence Interval (.093, .396) Pearson  Chi  
squre;21.846,  df;3,  which  implies  that  depression  symptoms  among  T2DM  
patients  are  5.2  times   higher  than  the  non – diabetic  general  population. 
 
These  results  correlates  with  the  previous  studies  of  Ali S  et  al, 2006,  
and  Anderson  et  al, 2001,  in which,  the  prevalence  rate  of  depression  among   
diabetic  patients  was  more  than  2 – 3  times  than  non – diabetic  individuals. 
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Also,  among  26  type 2  diabetic  women  participated   in  this  study 15  
women(57.7%)  had  depression,  and  among  the diabetic  men (n=54),  27  
diabetic  patients (50%)  had  depression. These   results  correlates  with  the  
previous  studies  of  Nanjundappa G  et  al,  1986,  Nichols  et  al,  2003, Goldney  
RD  et  al,  2004,  and   Shaban  et  al,  2006,  showed  that  an  increased  
prevalence  of  depression  among  type 2  diabetic  women  than  type 2  diabetic 
men. 
 
The  socio – demographic  factors  significantly  influences  the  occurrence  
of  depression  in  type 2  diabetic  patients. (3rd  hypothesis). 
 
About   the  educational  status,  among  5 illiterate  type 2  diabetic  
patients3  had  depression symptoms (7.1%),  primary  school  level;  11  patients 
(26.2%),Middle  school  level;  10  patients (23.8%),  High  school  level;  12  
patients (28.6%), Under  graduate  level; 6  patients (14.3%),  and  in  the  
Profession  level  nil  patients  reported. (Chi – Square;6.968a,  df;5) 
 
 
 
  In  the  control  group,  illiterate  3  patients (21.4%), Primary  school;  4  
patients (28.6%),  middle  school;  3  patients (21.4%),  high   school;  1  patient 
(7.1%), UG level;  2  patients (14.3%),   Professional;  1  patient (7.1%)  were  
reported  as  had  depression symptoms  or  varying  degree.( Chi – Square;6.510b,  
df;5).These  results  showed  the  association  of  low  education  and  depression  
as  already  demonstrated  by  Anne  Ergum  et  al,  2005. 
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In  the  Socio  Economic  Status  (SES),  among  type 2  diabetic  patients  
lower  SES  class  had    depression  symptoms  in  25  patients (59.5%),  and  in  
middle  SES  class  17  patients  (40.5%), and  in  the  non – diabetic  individuals  
lower  SES;  7  Patients (50%),  middle  SES;  6 patients  (17.1%),  and  in  upper  
SES;  1  patient  (7.1%)  had  depression  symptoms. (Chi – Square  case;0.385, 
control; 0.544). 
 
About   the  income  status, income  less  than  Rs. 5000  participated  more  
in  this  study  both  in  case  and  control  groups  (cases; 45 - 56.2% ,  controls; 42 
– 52.5%).  Among  these  25 type 2  diabetic  patients (59.5%)  had  depressive  
symptoms;   and  in  the  control  group,  7  individuals (50%)  had  depressive  
symptoms. These  results  shows  that  income  is  a  significant  factor  in  the  
causation  of  depression. Chi – Square; 0.691, df; 2. 
 
About  the  residence, the  participants  in  the  urban  region  was  54 
(67.5%)  in  case  group,  55 (68.75%)  in  control  group,   and  in  the  rural  
region  was  26 (32.5%)  in  case  group,  25 (31.25%)  in  the  control  group.  
Among  54  type 2  diabetic  patients  in  the  urban  region,  27  patients  had  
depressive  features (50%),  and  among  26  type 2  diabetic  patients  in  the  rural  
region  15  patients  had  depressive  symptoms (57.7%).  
 
In  concern  with the  2nd   hypothesis  of  increased  prevalence  of  anxiety  
among T2DM  patients, than  non – diabetic  individuals  also  correlates  with  this  
study. 
 
118 
 
This  study  showed  that  the  prevalence  of  anxiety  among  T2DM  
patients   is  more  than  3  times  than  the  non – diabetic  general  population.  In 
this  study  also,  among  80   type 2 diabetic  patients  41  patients  had  the 
symptoms  of  anxiety (51.25%),  and  among  the  control  group  15 individuals 
(18.75%)  had  symptoms  of  depression  in  varying  severity.  
 
Among  41  type 2  diabetic  patients  with  anxiety,  31  patients (38.8%)  
had  mild  anxiety,6  patients (7.5%)  had  mild  to  moderate  anxiety,  and  4 
patients (5.0%)  had  moderate  anxiety,  and   among 15  non – diabetic  
individuals, 11  individuals(13.8%)  had  mild  anxiety,  3  individuals (3.8%)  had  
mild  to  moderate  anxiety, and  1  individuals(1.2%)  had  moderate  anxiety. 
These  results  correlates  with  the  previous  studies  of  Hermanns  et  al, 2005,  
Janet  Thomas  et  al, 2003  reported  that  an  increased  prevalence  of  anxiety  
among  type 2  diabetic  patients. (Chi – squre;13.434, p – value;<0.001). Odds  
ratio; 4.12;  implies  that   anxiety  symptoms  among  type 2  diabetic  patients  are  
4.12  times  more  than  non – diabetic  individuals.  
 
 Also,  among  26  type 2  diabetic  women  participated   in  this  study 21  
women (80.7%)  had  anxiety  symptoms  of  varying  degree,  and  among 54 type 
2 diabetic  men (n=54),  20  diabetic  patients (37.03%)  had  anxiety  symptoms. 
These  results  also  similar  that  of  previous  studies  by  Grigsby  et  al, 2002,  
Hermanns  et  al, 2005,  Shaban  et  al, 2006,   Fisher  et  al, 2008. 
 
The  socio – demographic  factors  also  influences  significantly  in  the   
occurrence  of  anxiety  symptoms  in  type 2  diabetic  patients. (3rd  hypothesis) 
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In   concern  with  the  education  level,  both  in  T2DM  patients  and  in  
the  non – diabetic  individuals  group,  low  education  plays  an  important  role  
the  causation  of  anxiety. Education  level  up  to  middle  school  groups  had  
more  anxiety  symptoms (Cases; 14 (34.1%),  controls; 6 (40%). These  results  
correlates  with  the  previous  study  by  Janet  Thomas  et  al, 2003. 
 
In  the  Socio  Economic  status,  low  socio  economic  status  group  both   
in  case  and  control  group  had  significant  increased  risk  of  anxiety symptoms  
(Case; 56.1%),  Control; 80%). These  results  shows  that,  low  economic  status   
plays  a  vital  role  in  the  production  of  anxiety  features.  
 
About  the  income,  more  anxiety  symptoms  present  among  income  less 
than  Rs.5000,  both  in  type 2 diabetic  patients  and  in  the  control  group.  
Among  45  T2DM  patients  in this  income  group,  23  patients  had  varying  
degrees  of  anxiety  symptoms (51.1%),  and  in  the  control  group,  among 42  
individuals  only  12  had  anxiety  symptoms (28.6%). 
 
About  the  residence, the  participants  in  the  urban  region  was  54 
(67.5%)  in  case  group,  55 (68.75%)  in  control  group,   and  in  the  rural  
region  was  26 (32.5%)  in  case  group,  25 (31.25%)  in  the  control  group.  
Among  54  type 2  diabetic  patients  in  the  urban  region,  27  patients  had  
anxiety  symptoms (50%),  and  among  26  type 2  diabetic  patients  in  the  rural  
region  14  patients  had  anxiety  symptoms (53.8%).  
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These  results  shows  that,  the  predicting  factors  of  socio  economic  
status, education,  age,  sex,  and  income  were  significantly  associated  with  
depression  and  as  well  as  with  anxiety,  which  was  already  demonstrated  by  
Edede  et  al,  2003,  Nichols  et  al,  2003,  and  Goldney  RD  et  al,  2004.   
 
In  concern  with  the  association  of  duration  and  age  of  onset  of  
T2DM  most  of  the  cases  had  diabetes  in  the  30 -40 years. (Chi – 
Square;13.207,  p- value; 0.05).   
 
In  the  4th  hypothesis  of   the  Quality  of  Sexual  Function,  56.2%  (n=45)  
of  the T2DM  patients  had  sexual  dysfunction  in  varying  degrees. Among  45  
patients  of T2DM,  22  patients  had  mild  degree  of  sexual  dysfunction 
(27.5%),  16  patients  had  moderate  degree  of  sexual  dysfunction (20%),  and  
7  patients  had  severe  degree (8.8%).  In  the  control  group,  only  25%  (n= 20) 
of the  individuals  had  varying  degrees  of  sexual  dysfunction, among  them  
mild; 8 (10%),  moderate; 10 (12.5%),  and  severe;  2 (2.5%). Odds  ratio; 3.85,  
p- value 0.001  implies  statistically  significant; i.e. in  type 2  diabetic  patients  
sexual  dysfunction  is  more  than  3.85  times  than  non – diabetic  general  
population.  
 
In  the  psycho – somatic  quality  of  life,  75%  (n=60) of  the  type  2  
diabetic  patients  had  complaints  or  problems  in  this  domain,  where  as  in  
non – diabetic  control  group  only  46.2% (n=37) . Among  60  T2DM  patients,  
milder  degree; 25 (31.2%),  moderate  degree; 19 (23.8%),  and  the  severe  
degree; 16 (20%),  and  in  the  control  group  mild; 18 (22.5%),  moderate; 12 
(15%),  and  the  severe; 7 (8.8%)  were  reported. p – value; 0.002. Significant. 
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Odds  ratio; 3.486;  implies  that  Psycho – somatic  quality  of  life  among  T2DM  
patients  is  3.5  times  affected  more,  than  with  non – diabetic  individuals. 
 
In  the  sexual  activity,  78.8%  (n=63) of  the T2DM  patients  had  
complaints  or  problems  in  this  domain,  where  as  in  non – diabetic  control  
group  only  57.5% (n=46) . Among  63  T2DM  patients, milder  degree; 13 
(16.2%),  moderate degree; 9 (11.2%),  and  the  severe  degree; 41 (51.2%),  and  
in  the  control  group  mild; 19 (23.8%),  moderate; 11(13.8%),  and  the  severe; 
16 (20%)  were  reported. p – value; <0.005. Significant. Odds  ratio; 2.74;  implies  
that  sexual  activity  among  T2DM  patients  is  2.74  times  affected  more,  than  
with  non – diabetic  individuals. 
In  the  sexual  (dys) function  self – view,  72.5%  (n=58) of  the  type  2  
diabetic  patients  had  complaints  or  problems  in  this  domain,  where  as  in  
non – diabetic  control  group  only  47.5% (n=38) . Among  58  T2DM  patients,  
milder  degree; 20 (25%),  moderate  degree; 21 (26.2%),  and  the  severe  degree; 
17 (21.2%),  and  in  the  control  group  mild; 17 (21.2%),  moderate; 16(20%),  
and  the  severe; 5 (6.2%)  were  reported. p – value; <0.005. Significant. Odds 
ratio; 2.91;  implies  that  sexual  (dys) function  self – view  among  T2DM  
patients  is  2.9  times  affected  more,  than  with  non – diabetic  general 
population. 
 
In  the  sexual  (dys)function  partner – view,  76.2%  (n=61) of  the  type 2  
diabetic  patients  had  complaints  or  problems  in  this  domain,  where  as  in  
non – diabetic  control  group  only  45% (n=36) . Among  61  T2DM  patients,  
milder  degree; 13 (16.2%),  moderate  degree; 19 (23.28%),  and  the  severe  
degree; 29 (36.2%),  and  in  the  control  group  mild; 9 (11.2%),  moderate; 
12(15%),  and  the  severe; 15 (18.8%)  were  reported. p – value; <0.005. 
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Significant. Odds  ratio; 3.92;  implies  that  sexual  (dys) function  partner – view  
among  T2DM  patients  is  3.9  times  affected  more,  than  with  non – diabetic  
general  population. 
 
In  concern  with  the  5th   hypothesis  of  Role  of  sexuality  and  
menopause  in  association  with  QSF  total  score,  in  type 2  diabetic  patients   
the  Role  of  Sexuality  Chi – square  value; 17.443,  p – value; 0.001,  the  
menopause  status  Chi – square  value; 10.549,  p – value;< 0.001,  which  is  
statistically  significant. Also,  in  the  control  group,  the  Role  of  sexuality  had  
Chi – Square value; 8.598, p – value; < 0.05,  and  the  menopause  status  Chi – 
square  value  was  18.619,  p- value;< 0.001,  which  implies  that,  role  of  
sexuality and  menopause  status  were  significantly  impair  the  quality  of  
sexual  function.  
 
In  addition  to  these  results,  among  160  participants  29  had  both  depression  
and  anxiety  symptoms (18%). Among  these  29,  23  were  T2DM (79%),  and  
remaining  6  were  non – diabetic  general  population (21%). Odds  ratio; 4.97,  
which  implies  that,  presence  of  both  anxiety  and  depression  symptoms  
among  T2DM  patients  was  5  times  higher  than  non – diabetic  general  
population. 
 
 
 
 
 
123 
 
 
 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION: 
 
1. The  prevalence  of  depression  in  T2DM patients  is  3 to 5 times   
higher  than   the  non – diabetic  individuals i.e. General  population. 
 
2. The  prevalence  of  anxiety  symptoms  in  T2DM patients  is  2 to 3   
times  higher   than  with  non – diabetic  individuals (General  population). 
 
3.The  socio – demographic  factors  like  socio economic  status,  income,   
education,  age,  sex  and  the  residence  are  significantly  associated  with  the   
causation  of  depression  and  anxiety  among  type 2  diabetic  patients. 
 
4. The  quality  of  sexual  function  is  significantly  affected  among  T2DM 
patients,  which  is  3- 4 times  more  than  with  non – diabetic  individuals.  
 
5. The  psycho – somatic  quality  of  life  is  3.5 times  affected  more  in  T2DM 
patients  than  the  non – diabetic  individuals. 
 
6. The  Role  of  sexuality  and  the  menopause  status  are  significantly  affects   
the  quality  of  sexual  function  both  in  diabetic  patients  and  in  non – diabetic   
individuals,  but  affects  more  in  T2DM  patients. 
 
7. The  presence  of  both  anxiety  and  depression  symptoms  among  T2DM  
patients  was  5  times  higher  than  non – diabetic  general  population. 
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LIMITATIONS  OF  THE  STUDY 
 
1. Only  a   small  number  of  samples (80  Cases,  80  Controls) were  participated  
    in  this  study. 
 
2. The  study  was  done  at  a  single  point  of  time,   which  prevents  episodic  
     nature  of  depression  and  anxiety  symptom  evaluation. 
 
3. The  complications  of  diabetes  excluded  in  this  study,  because  of   
    confounding  factors,  because  of  that  the  severe  and  extreme  degrees  of   
    depression  and  anxiety  symptoms  not  reported  in  this  study. So,  a  study   
    with  complications  may  yield  an  exact  results. 
 
4. Since,  this  is  a  comparative  study,    particular  population  residing  near  to   
   this  hospital  only  participated  in  this  study. A  large  community  based   
   study  including  various  population  is  needed  to  evaluate  the  sexual  
   dysfunction.   
 
5. Even  though  the  complete  review  of  OP records  regarding  the  glycemic   
    control,  the  best  indicator  of  glycemic  control  like  HbA1C  level   did  not   
    available  for  this  study. 
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RECOMMENDATIONS. 
 
1. This  study  shows  that,  an  increased  rate  of  depression,  anxiety  and  
    sexual  dysfunction  among  type 2  diabetic  patients.  So,  it  is  recommended   
    that  every  type 2  diabetic  individual  must  need consultation  liaison    
    psychiatry  to  identify  any  psychiatric  illness,  to  prevent  or  postpone  their   
    complications,  since  both  mutually  worsen  each other. 
 
2. This  study  shows  that,  the  quality  of  sexual  function  is  significantly   
    affected  in  every  another  patient  in  type 2  diabetes,  even  without  any   
    complications. So,  it  is  mandatory  to  do  a  Psycho  sexual  evaluation  to   
    prevent  marital  disharmony  and  it’s   related  events. 
 
3. Further,  a  large  population  study  is  needed  to  evaluate the  sexual   
    dysfunction  among  diabetic  patients  in  a  community  set  up, to  obtain   
   an  exact  results. 
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                                                           PROFORMA  
DEMOGRAPHIC FACTORS 
Name: 
Age:  31-35,     36-40,    41-45,    46-50 Years.                                             
Sex:   (1).Male         (2).Female 
Education:    (1). Illiterate        (2). Primary-school         (3).Middle-school          
(4).High-school        (5).Under-graduate          (6). Post-graduate        (7). 
Professional. 
Religion:  (1).Hindu.       (2). Christian.         (3). Muslim.          (4). Others. 
Family:  (1). Nuclear.          (2). Joint family. 
Socio-Economic  status:   (1). Lower SES.      (2). Middle SES.          (3). Upper 
SES. 
Income:     (1).Rs: less  than 5000,       (2).Rs: 5000-10000,         (3).Rs: more  than 
10000. 
Marital  status:  (1). Married.         (2). Un  married.          (3). Married-seperated           
(4).Widowed. 
Occupation:   (1). Un-employed     (2). Un skilled worker       (3). Semi-skilled 
worker     (4). Skilled worker  (5).Farmer,  clerical,  self employed       (6).Semi-
profession        (7).Profession. 
Residence:  (1). Urban        (2). Rural 
 
DISEASE FACTORS: 
1. Age  of  onset: 
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2. Duration  of  Diabetes:  Minimum  6  months 
3. Glycemic  control  in  past   6 months:   (1). Good       (2). Fair       (3).Poor. 
4. Presence  of  complications:  (0). Absent        (1).Present. 
5. BDI  score: 
0-10:  These  ups  and  down  are  considered  normal (0) 
11-16: Mild  mood   disturbance (1) 
17-20: Border line clinical  depression  (2) 
21-30: Moderate  depression (3) 
31-40: Severe  depression (4) 
Over 40: Extreme  depression (5). 
6. HAM-A  Score: 
Not  present (0) 
<17: Mild severity(1) 
18-24: Mild  to  moderate  severity(2) 
25-30: Moderate  to  severe(3) 
>30: Severe.(4) 
 
7. Menopause   Status:   (0). No      (1). Yes. 
8. Sexual   Partner:  (0). No       (1). Yes. 
9. Sexual   Contact   During  Last  Month:    (0). No         (1). Yes          (2). 
Missing. 
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10. Sexual  Partner  For  How Long: 
     >10  Years: (1) 
     7-10  Years: (2) 
      4-6  Years: (3) 
      1-3  Years: (4) 
      6-12  Months: (5) 
      <6  Months: (6) 
       No  Sex: (7) 
11.Role of Sexuality: 
      Less   Important: (1) 
      More  Important: (2) 
      Very  Important: (3) 
12. QSF:    Psycho  Somatic  QoL: 
       ≤ 15: No,  Little (0) 
       16-24:  Mild (1) 
       25-34:  Moderate (2) 
       ≥35:  Severe (3). 
   Sexual  Activity  Level: 
        ≤ 17: No,  Little (0) 
       18-23:  Mild (1) 
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       24-26:  Moderate (2) 
       ≥27:  Severe (3). 
 Sexual  (Dys)  Function   -  Self  View: 
       ≤ 9: No,  Little (0) 
       10-15:  Mild (1) 
       16-19:  Moderate (2) 
       ≥20:  Severe (3).  
 Sexual  (Dys)  Function   -  Partner  View: 
       ≤ 5: No,  Little (0) 
       6-8:  Mild (1) 
       9-11:  Moderate (2) 
       ≥12:  Severe (3). 
 
 
 QSF – Total  Score: 
       ≤ 54: No,  Little (0) 
       55-68:  Mild (1) 
       69-79:  Moderate (2) 
       ≥80:  Severe (3). 
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